<?xml version="1.0"?>
<Ontology xmlns="http://www.w3.org/2002/07/owl#"
     xml:base="http://www.semanticweb.org/general/ontologies/2023/0/OntoLoco_V1"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:xml="http://www.w3.org/XML/1998/namespace"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
     ontologyIRI="http://www.semanticweb.org/general/ontologies/2023/0/OntoLoco_V1">
    <Prefix name="" IRI="http://www.semanticweb.org/general/ontologies/2023/0/OntoLoco_V1"/>
    <Prefix name="owl" IRI="http://www.w3.org/2002/07/owl#"/>
    <Prefix name="rdf" IRI="http://www.w3.org/1999/02/22-rdf-syntax-ns#"/>
    <Prefix name="xml" IRI="http://www.w3.org/XML/1998/namespace"/>
    <Prefix name="xsd" IRI="http://www.w3.org/2001/XMLSchema#"/>
    <Prefix name="rdfs" IRI="http://www.w3.org/2000/01/rdf-schema#"/>
    <Annotation>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <Literal>OntoLoco: An Ontology for Virtual Reality Training of Locomotion Rehabilitation of Stroke Injury.</Literal>
    </Annotation>
    <Annotation>
        <AnnotationProperty abbreviatedIRI="owl:versionInfo"/>
        <Literal>V 1.1</Literal>
    </Annotation>
    <Declaration>
        <Class IRI="#Abdominal_Obesity"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Accelerometer"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Acute_Hypertension"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Acute_Myocardial_Infarction"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Adjusted_Clinical_Group"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Age_Factor"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Airway_Breathing_Circulation_Control"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Anemia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Angioplasty"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Animal_Model_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Anticoagulation_Drugs_Therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Antihypertensive_Drugs_Therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Antioxidants"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Antiplatelet_Drugs_Therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Aplastic_Anemia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Application"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Arrhythmia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Arterial_Circulation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Arterial_Hypertension"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Arteriovenous_Malformation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Automotive"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Binge_Alcohol_Drinking"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Blood_Pressure_Control"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Blood_Sugar_Control"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Body_Suit"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Brain_Anatomy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Brain_Region"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Brain_Tumor"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cardiac_Arrest"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cardiac_Imaging_Biomarkers_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cardiac_Monitoring"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cardiac_Related_Comorbidity"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cardiac_Risk_Factor"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Carotid_Artery_Stenosis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Carotid_Endarterectomy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Carotid_Revascularization"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cell_Culture_Model_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cerebral_Aneurysm"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Charlson_Comorbidity_Index"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Chronic_Blood_Transfusion"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Chronic_Hypertension"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Chronic_Kidney_Insufficiency"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Comorbidity"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Comorbidity_Severity_Index"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Complication"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Component"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Computer"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Computer_Model_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Congestive_Heart_Failure"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Constipation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Coronary_Artery_Disease"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Coronary_Heart_Disease"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cryptogenic_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cumulative_Illness_Rating_Scale"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Damentia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Deep_Venous_Thrombosis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Dehydration"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Depression"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Device_Control_Button"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Devices"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Diabetes_Mellitus"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Diagnosis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Diagnosis_Cost_Group"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Dietary_Factor"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Dietary_Habit"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Differential_Diagnosis_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Digital_Sound_Editing"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Drug_Abuse"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Dural_Venous_Sinus"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Dysphagia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Education"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Education_Prevention"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Electrocardiographic_Abnormality"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Electrophysiological_Biomarkers_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Electtrocardiographic_Abnormality"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Elevated_Cardiac_Enzyme"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Elevated_Cardiac_Troponin"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Endothelial_Dysfunction"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Estrogen_Replacement_Therapy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Etiology_of_Hemorrhagic_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Etiology_of_Ischemic_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Evaluation_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Familial_Combined_Hyperlipidemias"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Familial_Hypertriglyceridemia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Family_History_of_stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Faulty_Heart_Valves"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Fiber_Optics"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Fully_Immersive"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Functional_Comorbidity_Index"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Gaming"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Gastritis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Gastrointestinal_Bleeding"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Gender"/>
    </Declaration>
    <Declaration>
        <Class IRI="#General_Treatment_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Genetic_Risk_Factor"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Geographic_Area"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Google_Cardboard_Headset"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Gyroscope"/>
    </Declaration>
    <Declaration>
        <Class IRI="#HTC_VIVE_Headset"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Haptic_Feedback_System"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hardware"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Headset"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Headsets"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Healthcare"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Heart_Failure"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hemostatic_Factor"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Histological_Biomarkers_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#History_of_Recent_Infection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#HostDevice"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hypercholesteremia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hyperglycemia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hyperlipidaemia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hyperlipidemia_due_to_Type_2_Diabetes_Mellitus"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hyperlipoproteinemia_Type_I"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hyperlipoproteinemia_Type_II"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hyperlipoproteinemia_Type_III"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hyperlipoproteinemia_Type_IV"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hyperlipoproteinemia_Type_V"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hyperlipoproteinemias"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hyperlipoproteinnemia_Type_IV"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hyperlipoproteinnemia_Type_V"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hyperruricemia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hypertension"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hypertention"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hypertriglyceridemia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hypoxemia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Immersion"/>
    </Declaration>
    <Declaration>
        <Class IRI="#In_Silico_Model_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#In_Vitro_Model_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#In_Vivo_Model_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#InputDevices"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Interactivity"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Intracerebral_Hemorrhage"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Intracranial_Hemorrhage"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Ischemic_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Joystick"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Laptop"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Leukoaraiosis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Life_Style_Modification"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Life_Style_modification"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Liu_Index"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Low_Birth_Weight"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Low_Hemoglobin_Level"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Magnetometer"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Mathematical_Model_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Measurement_of_Body_Mass_Index"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Measures_of_Comorbidity"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Mental_Immersion"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Metabolic_disease"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Model_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Model_of_Stroke_Care"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Molecular_Biomarkers_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Motion_Tracker"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Myocardial_Infarction"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Neoplasm"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Network_Model_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Neurogenic_Bladder"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Neuroimaging_Biomarkers_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Non_Immersive"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Nonmodifiable_Risk_Factors"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Nutritional_Counseling"/>
    </Declaration>
    <Declaration>
        <Class IRI="#OMICS_Biomarkers_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#OWLClass_34bc4341_294f_46be_a29d_ed6e1061ea3a"/>
    </Declaration>
    <Declaration>
        <Class IRI="#OWLClass_3a1ae59a_d940_49d6_b133_1b7ad71c26f9"/>
    </Declaration>
    <Declaration>
        <Class IRI="#OWLClass_c2830a4c_f4d1_403d_8bbf_dfa0174f1d9f"/>
    </Declaration>
    <Declaration>
        <Class IRI="#OWLClass_e8555bce_f177_4aea_86c3_f65555f414b7"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Obesity"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Oculus_Rift_Headset"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Orpington_Prognostic_Scale"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Osteoarthritis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Outcome"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Oxygen_Desaturation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#PC"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pathophysiology_Hemorrhagic_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pathophysiology_of_Ischemic_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pathway"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pediatric_Ischemic_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Physical_Biomarkers_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Physical_Immersion"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Piezoelectric_Sensors"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Playstation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Playstation_VR_Headset"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pneumonia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Poor_Nutritional_Status"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Porcine_Ischemic_Stroke_Model"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Post_Stroke_Comorbidity"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Poststroke_Hyperglycemia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Posttranscriptional_Gene_Silencing"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Prestroke_Comorbidity"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Primary_Hypercholesteremia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Primary_Hypertriglyceridemia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Primary_Prevention_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Prior_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Process_Acceleration_Card"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Prognosis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Proximity_Sensor"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Pulmonary_Embolism"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Race"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Renal_Dysfunction"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Risk_Factor"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Risk_Factor_Reduction"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Samsung_VR_Headset"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Scales"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Screening_for_Diabetic_Mellitus"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Screening_for_Sleep_Apnea"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Secondary_Hypercholesteremia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Secondary_Hyperlipidemia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Secondary_Hypertriglyceridemia"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Secondary_Prevention_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Self_Monitoring_of_Blood_Pressure"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Semantic_Model_of_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Semi_Immersive"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Sensing_Glove"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Sensory_Displays"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Sensory_Feedback"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Shoulder_Pain"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Shwartz_Index"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Simulation_Software"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Smartphone"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Smoking"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Snoring"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Software"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Strain_Gauges"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stroke_Center"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stroke_Mimics"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stroke_Prevention"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stroke_Type"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Stroke_team"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Subarachnoid_Hemorrhage"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Symptom_of_Hemorrhagic_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Symptom_of_Ischemic_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Technologies"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Technology"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Telemedicine"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Telestroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Temperature_Control"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Tobacco_Use"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Tracking_Pad"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Tracking_System"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Training"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Treadmills"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Treatment"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Treatment_of_Hemorrhagic_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Treatment_of_Ischemic_Stroke"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Treatment_of_Pain_and_Anxiety"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Type_2_Diabetes_Mellitus"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Types"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Urinary_Tract_Infection"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Virtual_Reality"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Virtual_World"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Visual_Impairment"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;Diagnostic_evaluation&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;Jak-Stat_signaling_pathway&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;Mitogen-Activated_Protein_Kinase_Signaling_Pathway&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;Notch_signaling_pathway&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;Toll-like_receptor_signaling_pathway&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;angiopoietin_signaling_pathway&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;apoptotic_cell_death_pathway&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;brain-derived_neurotrophic_factor_signaling_pathway&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;c-Jun_N-terminal_kinases_MAPK_signaling_pathway&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;endoplasmic_reticulum_stress_-_the_unfolded_protein_response_pathway&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;homocysteine_metabolic_pathway&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;immune_response_pathway&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;inflammatory_response_pathway&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;lipid_metabolic_pathway&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;mTOR_signaling_pathway&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;necrosis_pathway&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;nuclear_factor_kappa_B_signaling_pathway&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;oxidative_stress_response_pathway&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;p38_MAPK_signaling_pathway&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;phosphatidylinositol_3-kinase-Akt_signaling_pathway&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#&apos;retinoic_acid_signaling_pathway&apos;"/>
    </Declaration>
    <Declaration>
        <Class IRI="#2D_Graphics_Software"/>
    </Declaration>
    <Declaration>
        <Class IRI="#3D_Modelling_Software"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Input/Output_Devices"/>
    </Declaration>
    <Declaration>
        <Class IRI="#chemokine_(C-C_motif)_ligand_2_signaling_pathway"/>
    </Declaration>
    <Declaration>
        <Class IRI="#nuclear_factor,_erythroid_2_like_2_signaling_pathway"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#OWLObjectProperty_2e92b949_4d60_48b4_b2f3_9b411f818aaa"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#OWLObjectProperty_31c75e97_ce08_416d_9f73_8e8d925625cb"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#OWLObjectProperty_5615cbc1_65c9_4e29_98d3_377529b10061"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#OWLObjectProperty_84d46f2b_d0ec_4792_bbcf_0f8339f7b468"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#OWLObjectProperty_c47210a3_bde8_4bcc_bf78_95c620906491"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#OWLObjectProperty_db528468_dcd4_4048_8fd7_eed7a668add5"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#OWLObjectProperty_ee1a2701_b93b_4a04_b72d_3bfd6ae3a7eb"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty IRI="#defination"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty IRI="#references"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty IRI="#source"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty IRI="#synonyms"/>
    </Declaration>
    <EquivalentClasses>
        <Class IRI="#Adjusted_Clinical_Group"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Measures_of_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Age_Factor"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Nonmodifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Airway_Breathing_Circulation_Control"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#General_Treatment_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Anemia"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Prestroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Angioplasty"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Secondary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Animal_Model_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Model_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Anticoagulation_Drugs_Therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Secondary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Antihypertensive_Drugs_Therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Secondary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Antioxidants"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_ee1a2701_b93b_4a04_b72d_3bfd6ae3a7eb"/>
            <Class IRI="#Primary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Antiplatelet_Drugs_Therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Secondary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Arterial_Circulation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_5615cbc1_65c9_4e29_98d3_377529b10061"/>
            <Class IRI="#Brain_Anatomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Arteriovenous_Malformation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Modifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Automotive"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_2e92b949_4d60_48b4_b2f3_9b411f818aaa"/>
            <Class IRI="#Application"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Binge_Alcohol_Drinking"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Modifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Blood_Pressure_Control"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#General_Treatment_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Blood_Sugar_Control"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#General_Treatment_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Body_Suit"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Devices"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Brain_Anatomy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_2e92b949_4d60_48b4_b2f3_9b411f818aaa"/>
            <Class IRI="#Diagnosis"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Brain_Region"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_5615cbc1_65c9_4e29_98d3_377529b10061"/>
            <Class IRI="#Brain_Anatomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Cardiac_Arrest"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Complication"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Cardiac_Imaging_Biomarkers_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Cardiac_Monitoring"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#General_Treatment_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Cardiac_Related_Comorbidity"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Prestroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Cardiac_Risk_Factor"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Modifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Carotid_Artery_Stenosis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Modifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Carotid_Endarterectomy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Secondary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Carotid_Revascularization"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Secondary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Cell_Culture_Model_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Model_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Cerebral_Aneurysm"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Modifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Charlson_Comorbidity_Index"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Measures_of_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Chronic_Blood_Transfusion"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Secondary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Chronic_Kidney_Insufficiency"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Modifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Comorbidity"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_2e92b949_4d60_48b4_b2f3_9b411f818aaa"/>
            <Class IRI="#Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Comorbidity_Severity_Index"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Measures_of_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Computer_Model_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Model_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Congestive_Heart_Failure"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Complication"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Constipation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Post_Stroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Cryptogenic_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Ischemic_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Cumulative_Illness_Rating_Scale"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Measures_of_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Damentia"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Prestroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Damentia"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Stroke_Mimics"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Deep_Venous_Thrombosis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pulmonary_Embolism"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Dehydration"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Complication"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Depression"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Post_Stroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Device_Control_Button"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Devices"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Diabetes_Mellitus"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Prestroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Diagnosis_Cost_Group"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Measures_of_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Dietary_Factor"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Modifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Dietary_Habit"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Primary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Differential_Diagnosis_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_ee1a2701_b93b_4a04_b72d_3bfd6ae3a7eb"/>
            <Class IRI="#Diagnosis"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Drug_Abuse"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Modifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Dural_Venous_Sinus"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_5615cbc1_65c9_4e29_98d3_377529b10061"/>
            <Class IRI="#Brain_Anatomy"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Dysphagia"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Complication"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Education"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_2e92b949_4d60_48b4_b2f3_9b411f818aaa"/>
            <Class IRI="#Application"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Education_Prevention"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Secondary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Electrocardiographic_Abnormality"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Complication"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Electrocardiographic_Abnormality"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Prestroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Electrophysiological_Biomarkers_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Electtrocardiographic_Abnormality"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Complication"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Elevated_Cardiac_Enzyme"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Complication"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Elevated_Cardiac_Troponin"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Elevated_Cardiac_Enzyme"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Endothelial_Dysfunction"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Modifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Estrogen_Replacement_Therapy"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Modifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Etiology_of_Hemorrhagic_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_5615cbc1_65c9_4e29_98d3_377529b10061"/>
            <Class IRI="#Intracranial_Hemorrhage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Etiology_of_Ischemic_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_5615cbc1_65c9_4e29_98d3_377529b10061"/>
            <Class IRI="#Ischemic_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Evaluation_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_ee1a2701_b93b_4a04_b72d_3bfd6ae3a7eb"/>
            <Class IRI="#Diagnosis"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Family_History_of_stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Nonmodifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Functional_Comorbidity_Index"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Measures_of_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Gaming"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_2e92b949_4d60_48b4_b2f3_9b411f818aaa"/>
            <Class IRI="#Application"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Gastritis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Post_Stroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Gastrointestinal_Bleeding"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Complication"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Gender"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Nonmodifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#General_Treatment_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_ee1a2701_b93b_4a04_b72d_3bfd6ae3a7eb"/>
            <Class IRI="#Treatment"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Genetic_Risk_Factor"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Nonmodifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Geographic_Area"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Nonmodifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Haptic_Feedback_System"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Devices"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Headsets"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Devices"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Healthcare"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_2e92b949_4d60_48b4_b2f3_9b411f818aaa"/>
            <Class IRI="#Application"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hemostatic_Factor"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Modifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Histological_Biomarkers_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#History_of_Recent_Infection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Modifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#HostDevice"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_5615cbc1_65c9_4e29_98d3_377529b10061"/>
            <Class IRI="#Devices"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hyperglycemia"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Metabolic_disease"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hyperglycemia"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Prestroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hyperglycemia"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_ee1a2701_b93b_4a04_b72d_3bfd6ae3a7eb"/>
            <Class IRI="#Blood_Sugar_Control"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hyperlipidaemia"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Prestroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hyperruricemia"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Modifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hypertension"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Prestroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hypertention"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Modifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Hypoxemia"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Modifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Immersion"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Component"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#In_Silico_Model_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Model_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#In_Vitro_Model_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Model_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#In_Vivo_Model_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Model_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Interactivity"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Component"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Intracerebral_Hemorrhage"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Intracranial_Hemorrhage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Intracranial_Hemorrhage"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Stroke_Type"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Ischemic_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Stroke_Type"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Joystick"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Devices"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Laptop"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Devices"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Leukoaraiosis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Prestroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Life_Style_Modification"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Primary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Life_Style_modification"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Secondary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Liu_Index"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Measures_of_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Low_Birth_Weight"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Nonmodifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Low_Hemoglobin_Level"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Prestroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Mathematical_Model_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Model_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Measurement_of_Body_Mass_Index"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_5615cbc1_65c9_4e29_98d3_377529b10061"/>
            <Class IRI="#Secondary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Measures_of_Comorbidity"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_2e92b949_4d60_48b4_b2f3_9b411f818aaa"/>
            <Class IRI="#Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Metabolic_disease"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Modifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Model_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Model_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Model_of_Stroke_Care"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Model_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Modifiable_Risk_Factors"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_ee1a2701_b93b_4a04_b72d_3bfd6ae3a7eb"/>
            <Class IRI="#Risk_Factor"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Molecular_Biomarkers_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Motion_Tracker"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Devices"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Neoplasm"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Prestroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Network_Model_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Model_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Neurogenic_Bladder"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Post_Stroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Neuroimaging_Biomarkers_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Nonmodifiable_Risk_Factors"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_ee1a2701_b93b_4a04_b72d_3bfd6ae3a7eb"/>
            <Class IRI="#Risk_Factor"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Nutritional_Counseling"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Secondary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#OMICS_Biomarkers_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#OWLClass_34bc4341_294f_46be_a29d_ed6e1061ea3a"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Primary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#OWLClass_3a1ae59a_d940_49d6_b133_1b7ad71c26f9"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_ee1a2701_b93b_4a04_b72d_3bfd6ae3a7eb"/>
            <Class IRI="#General_Treatment_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#OWLClass_c2830a4c_f4d1_403d_8bbf_dfa0174f1d9f"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Intracranial_Hemorrhage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#OWLClass_e8555bce_f177_4aea_86c3_f65555f414b7"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#General_Treatment_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#OWLClass_e8555bce_f177_4aea_86c3_f65555f414b7"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Primary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#OWLClass_e8555bce_f177_4aea_86c3_f65555f414b7"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Secondary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Obesity"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Prestroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Orpington_Prognostic_Scale"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Measures_of_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Osteoarthritis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Post_Stroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Outcome"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_5615cbc1_65c9_4e29_98d3_377529b10061"/>
            <Class IRI="#Evaluation_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Oxygen_Desaturation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Complication"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#PC"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Devices"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Pathophysiology_Hemorrhagic_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_2e92b949_4d60_48b4_b2f3_9b411f818aaa"/>
            <Class IRI="#Intracranial_Hemorrhage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Pathophysiology_of_Ischemic_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_2e92b949_4d60_48b4_b2f3_9b411f818aaa"/>
            <Class IRI="#Ischemic_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Pathway"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_2e92b949_4d60_48b4_b2f3_9b411f818aaa"/>
            <Class IRI="#Diagnosis"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Pediatric_Ischemic_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Ischemic_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Physical_Biomarkers_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Playstation"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Devices"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Pneumonia"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Complication"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Poor_Nutritional_Status"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Prestroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Porcine_Ischemic_Stroke_Model"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Model_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Post_Stroke_Comorbidity"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_5615cbc1_65c9_4e29_98d3_377529b10061"/>
            <Class IRI="#Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Poststroke_Hyperglycemia"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Post_Stroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Posttranscriptional_Gene_Silencing"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_5615cbc1_65c9_4e29_98d3_377529b10061"/>
            <Class IRI="#Ischemic_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Prestroke_Comorbidity"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Primary_Prevention_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Stroke_Prevention"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Prior_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Prestroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Prognosis"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_5615cbc1_65c9_4e29_98d3_377529b10061"/>
            <Class IRI="#Evaluation_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Pulmonary_Embolism"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Complication"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Race"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Nonmodifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Renal_Dysfunction"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Prestroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Risk_Factor_Reduction"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_ee1a2701_b93b_4a04_b72d_3bfd6ae3a7eb"/>
            <Class IRI="#Primary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Scales"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_ee1a2701_b93b_4a04_b72d_3bfd6ae3a7eb"/>
            <Class IRI="#Evaluation_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Screening_for_Diabetic_Mellitus"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Secondary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Screening_for_Sleep_Apnea"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Primary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Secondary_Prevention_of_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Stroke_Prevention"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Self_Monitoring_of_Blood_Pressure"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Primary_Prevention_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Sensing_Glove"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Devices"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Sensory_Feedback"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Component"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Shoulder_Pain"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Post_Stroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Shwartz_Index"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Measures_of_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Smartphone"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Devices"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Smoking"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Modifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Snoring"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Modifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stroke_Center"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_ee1a2701_b93b_4a04_b72d_3bfd6ae3a7eb"/>
            <Class IRI="#General_Treatment_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stroke_Mimics"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_db528468_dcd4_4048_8fd7_eed7a668add5"/>
            <Class IRI="#Differential_Diagnosis_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Stroke_team"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_ee1a2701_b93b_4a04_b72d_3bfd6ae3a7eb"/>
            <Class IRI="#Evaluation_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Subarachnoid_Hemorrhage"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Intracranial_Hemorrhage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Symptom_of_Hemorrhagic_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_5615cbc1_65c9_4e29_98d3_377529b10061"/>
            <Class IRI="#Intracranial_Hemorrhage"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Symptom_of_Ischemic_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_5615cbc1_65c9_4e29_98d3_377529b10061"/>
            <Class IRI="#Ischemic_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Telemedicine"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_ee1a2701_b93b_4a04_b72d_3bfd6ae3a7eb"/>
            <Class IRI="#Evaluation_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Telestroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_ee1a2701_b93b_4a04_b72d_3bfd6ae3a7eb"/>
            <Class IRI="#Evaluation_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Temperature_Control"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#General_Treatment_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Tobacco_Use"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Modifiable_Risk_Factors"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Tracking_Pad"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Devices"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Training"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_2e92b949_4d60_48b4_b2f3_9b411f818aaa"/>
            <Class IRI="#Application"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Treadmills"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Devices"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Treatment"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_2e92b949_4d60_48b4_b2f3_9b411f818aaa"/>
            <Class IRI="#Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Treatment_of_Hemorrhagic_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_ee1a2701_b93b_4a04_b72d_3bfd6ae3a7eb"/>
            <Class IRI="#Treatment"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Treatment_of_Ischemic_Stroke"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_ee1a2701_b93b_4a04_b72d_3bfd6ae3a7eb"/>
            <Class IRI="#Treatment"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Treatment_of_Pain_and_Anxiety"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#General_Treatment_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Urinary_Tract_Infection"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Complication"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Virtual_World"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Component"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Visual_Impairment"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Post_Stroke_Comorbidity"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_5615cbc1_65c9_4e29_98d3_377529b10061"/>
            <Class IRI="#Diagnosis"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;Diagnostic_evaluation&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Evaluation_of_Stroke"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;Jak-Stat_signaling_pathway&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;Mitogen-Activated_Protein_Kinase_Signaling_Pathway&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;Notch_signaling_pathway&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;Toll-like_receptor_signaling_pathway&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;angiopoietin_signaling_pathway&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;apoptotic_cell_death_pathway&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;brain-derived_neurotrophic_factor_signaling_pathway&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;c-Jun_N-terminal_kinases_MAPK_signaling_pathway&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;endoplasmic_reticulum_stress_-_the_unfolded_protein_response_pathway&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;homocysteine_metabolic_pathway&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;immune_response_pathway&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;inflammatory_response_pathway&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;lipid_metabolic_pathway&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;mTOR_signaling_pathway&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;necrosis_pathway&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;nuclear_factor_kappa_B_signaling_pathway&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;oxidative_stress_response_pathway&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;p38_MAPK_signaling_pathway&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;phosphatidylinositol_3-kinase-Akt_signaling_pathway&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#&apos;retinoic_acid_signaling_pathway&apos;"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#Input/Output_Devices"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_5615cbc1_65c9_4e29_98d3_377529b10061"/>
            <Class IRI="#Devices"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#chemokine_(C-C_motif)_ligand_2_signaling_pathway"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <EquivalentClasses>
        <Class IRI="#nuclear_factor,_erythroid_2_like_2_signaling_pathway"/>
        <ObjectSomeValuesFrom>
            <ObjectProperty IRI="#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df"/>
            <Class IRI="#Pathway"/>
        </ObjectSomeValuesFrom>
    </EquivalentClasses>
    <SubClassOf>
        <Class IRI="#Abdominal_Obesity"/>
        <Class IRI="#Obesity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Accelerometer"/>
        <Class IRI="#Technologies"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Acute_Hypertension"/>
        <Class IRI="#Hypertension"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Acute_Myocardial_Infarction"/>
        <Class IRI="#Myocardial_Infarction"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Adjusted_Clinical_Group"/>
        <Class IRI="#Measures_of_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Age_Factor"/>
        <Class IRI="#Nonmodifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Airway_Breathing_Circulation_Control"/>
        <Class IRI="#General_Treatment_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Anemia"/>
        <Class IRI="#Prestroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Angioplasty"/>
        <Class IRI="#Secondary_Prevention_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Animal_Model_of_Stroke"/>
        <Class IRI="#Model_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Anticoagulation_Drugs_Therapy"/>
        <Class IRI="#Secondary_Prevention_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Antihypertensive_Drugs_Therapy"/>
        <Class IRI="#Secondary_Prevention_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Antioxidants"/>
        <Class IRI="#Primary_Prevention_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Antiplatelet_Drugs_Therapy"/>
        <Class IRI="#Secondary_Prevention_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Aplastic_Anemia"/>
        <Class IRI="#Anemia"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Application"/>
        <Class IRI="#Virtual_Reality"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Arrhythmia"/>
        <Class IRI="#Cardiac_Related_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Arterial_Circulation"/>
        <Class IRI="#Brain_Anatomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Arterial_Hypertension"/>
        <Class IRI="#Hypertension"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Arteriovenous_Malformation"/>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Automotive"/>
        <Class IRI="#Application"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Binge_Alcohol_Drinking"/>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Blood_Pressure_Control"/>
        <Class IRI="#General_Treatment_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Blood_Sugar_Control"/>
        <Class IRI="#General_Treatment_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Body_Suit"/>
        <Class IRI="#Input/Output_Devices"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Brain_Anatomy"/>
        <Class IRI="#Diagnosis"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Brain_Region"/>
        <Class IRI="#Brain_Anatomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Brain_Tumor"/>
        <Class IRI="#Neoplasm"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cardiac_Arrest"/>
        <Class IRI="#Complication"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cardiac_Imaging_Biomarkers_of_Stroke"/>
        <Class IRI="#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cardiac_Monitoring"/>
        <Class IRI="#General_Treatment_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cardiac_Related_Comorbidity"/>
        <Class IRI="#Prestroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cardiac_Risk_Factor"/>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Carotid_Artery_Stenosis"/>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Carotid_Endarterectomy"/>
        <Class IRI="#Secondary_Prevention_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Carotid_Revascularization"/>
        <Class IRI="#Secondary_Prevention_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cell_Culture_Model_of_Stroke"/>
        <Class IRI="#Model_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cerebral_Aneurysm"/>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Charlson_Comorbidity_Index"/>
        <Class IRI="#Measures_of_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Chronic_Blood_Transfusion"/>
        <Class IRI="#Secondary_Prevention_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Chronic_Hypertension"/>
        <Class IRI="#Hypertension"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Chronic_Kidney_Insufficiency"/>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Comorbidity"/>
        <Class IRI="#Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Comorbidity_Severity_Index"/>
        <Class IRI="#Measures_of_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Complication"/>
        <Class IRI="#Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Component"/>
        <Class IRI="#Virtual_Reality"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Computer"/>
        <Class IRI="#Hardware"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Computer_Model_of_Stroke"/>
        <Class IRI="#Model_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Congestive_Heart_Failure"/>
        <Class IRI="#Complication"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Constipation"/>
        <Class IRI="#Post_Stroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Coronary_Artery_Disease"/>
        <Class IRI="#Cardiac_Related_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Coronary_Heart_Disease"/>
        <Class IRI="#Cardiac_Related_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cryptogenic_Stroke"/>
        <Class IRI="#Ischemic_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cumulative_Illness_Rating_Scale"/>
        <Class IRI="#Measures_of_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Damentia"/>
        <Class IRI="#Prestroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Deep_Venous_Thrombosis"/>
        <Class IRI="#Pulmonary_Embolism"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Dehydration"/>
        <Class IRI="#Complication"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Depression"/>
        <Class IRI="#Post_Stroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Device_Control_Button"/>
        <Class IRI="#Input/Output_Devices"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Devices"/>
        <Class IRI="#Virtual_Reality"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Diabetes_Mellitus"/>
        <Class IRI="#Prestroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Diagnosis"/>
        <Class IRI="#Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Diagnosis_Cost_Group"/>
        <Class IRI="#Measures_of_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Dietary_Factor"/>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Dietary_Habit"/>
        <Class IRI="#Primary_Prevention_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Differential_Diagnosis_of_Stroke"/>
        <Class IRI="#Diagnosis"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Digital_Sound_Editing"/>
        <Class IRI="#Software"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Drug_Abuse"/>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Dural_Venous_Sinus"/>
        <Class IRI="#Brain_Anatomy"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Dysphagia"/>
        <Class IRI="#Complication"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Education"/>
        <Class IRI="#Application"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Education_Prevention"/>
        <Class IRI="#Secondary_Prevention_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Electrocardiographic_Abnormality"/>
        <Class IRI="#Prestroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Electrophysiological_Biomarkers_of_Stroke"/>
        <Class IRI="#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Electtrocardiographic_Abnormality"/>
        <Class IRI="#Complication"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Elevated_Cardiac_Enzyme"/>
        <Class IRI="#Complication"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Elevated_Cardiac_Troponin"/>
        <Class IRI="#Elevated_Cardiac_Enzyme"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Endothelial_Dysfunction"/>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Estrogen_Replacement_Therapy"/>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Etiology_of_Hemorrhagic_Stroke"/>
        <Class IRI="#Intracranial_Hemorrhage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Etiology_of_Ischemic_Stroke"/>
        <Class IRI="#Ischemic_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Evaluation_of_Stroke"/>
        <Class IRI="#Diagnosis"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Familial_Combined_Hyperlipidemias"/>
        <Class IRI="#Hyperlipidaemia"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Familial_Hypertriglyceridemia"/>
        <Class IRI="#Primary_Hypertriglyceridemia"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Family_History_of_stroke"/>
        <Class IRI="#Nonmodifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Faulty_Heart_Valves"/>
        <Class IRI="#Cardiac_Related_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Fiber_Optics"/>
        <Class IRI="#Sensing_Glove"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Fully_Immersive"/>
        <Class IRI="#Technology"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Functional_Comorbidity_Index"/>
        <Class IRI="#Measures_of_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Gaming"/>
        <Class IRI="#Application"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Gastritis"/>
        <Class IRI="#Post_Stroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Gastrointestinal_Bleeding"/>
        <Class IRI="#Complication"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Gender"/>
        <Class IRI="#Nonmodifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#General_Treatment_of_Stroke"/>
        <Class IRI="#Treatment"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Genetic_Risk_Factor"/>
        <Class IRI="#Nonmodifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Geographic_Area"/>
        <Class IRI="#Nonmodifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Google_Cardboard_Headset"/>
        <Class IRI="#Types"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Gyroscope"/>
        <Class IRI="#Technologies"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#HTC_VIVE_Headset"/>
        <Class IRI="#Types"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Haptic_Feedback_System"/>
        <Class IRI="#Input/Output_Devices"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hardware"/>
        <Class IRI="#Virtual_Reality"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Headset"/>
        <Class IRI="#Virtual_Reality"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Headsets"/>
        <Class IRI="#Input/Output_Devices"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Healthcare"/>
        <Class IRI="#Application"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Heart_Failure"/>
        <Class IRI="#Cardiac_Related_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hemostatic_Factor"/>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Histological_Biomarkers_of_Stroke"/>
        <Class IRI="#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#History_of_Recent_Infection"/>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#HostDevice"/>
        <Class IRI="#Devices"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hypercholesteremia"/>
        <Class IRI="#Hyperlipidaemia"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hyperglycemia"/>
        <Class IRI="#Prestroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hyperlipidaemia"/>
        <Class IRI="#Prestroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hyperlipidemia_due_to_Type_2_Diabetes_Mellitus"/>
        <Class IRI="#Secondary_Hyperlipidemia"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hyperlipoproteinemia_Type_I"/>
        <Class IRI="#Hyperlipoproteinemias"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hyperlipoproteinemia_Type_II"/>
        <Class IRI="#Hyperlipoproteinemias"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hyperlipoproteinemia_Type_III"/>
        <Class IRI="#Hyperlipoproteinemias"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hyperlipoproteinemia_Type_IV"/>
        <Class IRI="#Hyperlipoproteinemias"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hyperlipoproteinemia_Type_V"/>
        <Class IRI="#Hyperlipoproteinemias"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hyperlipoproteinemias"/>
        <Class IRI="#Hyperlipidaemia"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hyperlipoproteinnemia_Type_IV"/>
        <Class IRI="#Familial_Hypertriglyceridemia"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hyperlipoproteinnemia_Type_V"/>
        <Class IRI="#Familial_Hypertriglyceridemia"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hyperruricemia"/>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hypertension"/>
        <Class IRI="#Prestroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hypertention"/>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hypertriglyceridemia"/>
        <Class IRI="#Hyperlipidaemia"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hypoxemia"/>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Immersion"/>
        <Class IRI="#Component"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#In_Silico_Model_of_Stroke"/>
        <Class IRI="#Model_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#In_Vitro_Model_of_Stroke"/>
        <Class IRI="#Model_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#In_Vivo_Model_of_Stroke"/>
        <Class IRI="#Model_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#InputDevices"/>
        <Class IRI="#Hardware"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Interactivity"/>
        <Class IRI="#Component"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Intracerebral_Hemorrhage"/>
        <Class IRI="#Intracranial_Hemorrhage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Intracranial_Hemorrhage"/>
        <Class IRI="#Stroke_Type"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Ischemic_Stroke"/>
        <Class IRI="#Stroke_Type"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Joystick"/>
        <Class IRI="#Input/Output_Devices"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Laptop"/>
        <Class IRI="#HostDevice"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Leukoaraiosis"/>
        <Class IRI="#Prestroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Life_Style_Modification"/>
        <Class IRI="#Primary_Prevention_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Life_Style_modification"/>
        <Class IRI="#Secondary_Prevention_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Liu_Index"/>
        <Class IRI="#Measures_of_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Low_Birth_Weight"/>
        <Class IRI="#Nonmodifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Low_Hemoglobin_Level"/>
        <Class IRI="#Prestroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Magnetometer"/>
        <Class IRI="#Technologies"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Mathematical_Model_of_Stroke"/>
        <Class IRI="#Model_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Measurement_of_Body_Mass_Index"/>
        <Class IRI="#Secondary_Prevention_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Measures_of_Comorbidity"/>
        <Class IRI="#Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Mental_Immersion"/>
        <Class IRI="#Immersion"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Metabolic_disease"/>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Model_of_Stroke"/>
        <Class IRI="#Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Model_of_Stroke_Care"/>
        <Class IRI="#Model_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Modifiable_Risk_Factors"/>
        <Class IRI="#Risk_Factor"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Molecular_Biomarkers_of_Stroke"/>
        <Class IRI="#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Motion_Tracker"/>
        <Class IRI="#Input/Output_Devices"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Myocardial_Infarction"/>
        <Class IRI="#Cardiac_Related_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Neoplasm"/>
        <Class IRI="#Prestroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Network_Model_of_Stroke"/>
        <Class IRI="#Model_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Neurogenic_Bladder"/>
        <Class IRI="#Post_Stroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Neuroimaging_Biomarkers_of_Stroke"/>
        <Class IRI="#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Non_Immersive"/>
        <Class IRI="#Technology"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Nonmodifiable_Risk_Factors"/>
        <Class IRI="#Risk_Factor"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Nutritional_Counseling"/>
        <Class IRI="#Secondary_Prevention_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#OMICS_Biomarkers_of_Stroke"/>
        <Class IRI="#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#OWLClass_34bc4341_294f_46be_a29d_ed6e1061ea3a"/>
        <Class IRI="#Primary_Prevention_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#OWLClass_3a1ae59a_d940_49d6_b133_1b7ad71c26f9"/>
        <Class IRI="#General_Treatment_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#OWLClass_c2830a4c_f4d1_403d_8bbf_dfa0174f1d9f"/>
        <Class IRI="#Intracranial_Hemorrhage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#OWLClass_e8555bce_f177_4aea_86c3_f65555f414b7"/>
        <Class IRI="#General_Treatment_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Obesity"/>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Obesity"/>
        <Class IRI="#Prestroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Oculus_Rift_Headset"/>
        <Class IRI="#Types"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Orpington_Prognostic_Scale"/>
        <Class IRI="#Measures_of_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Osteoarthritis"/>
        <Class IRI="#Post_Stroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Outcome"/>
        <Class IRI="#Evaluation_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Oxygen_Desaturation"/>
        <Class IRI="#Complication"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#PC"/>
        <Class IRI="#HostDevice"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pathophysiology_Hemorrhagic_Stroke"/>
        <Class IRI="#Intracranial_Hemorrhage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pathophysiology_of_Ischemic_Stroke"/>
        <Class IRI="#Ischemic_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pathway"/>
        <Class IRI="#Diagnosis"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pediatric_Ischemic_Stroke"/>
        <Class IRI="#Ischemic_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Physical_Biomarkers_of_Stroke"/>
        <Class IRI="#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Physical_Immersion"/>
        <Class IRI="#Immersion"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Piezoelectric_Sensors"/>
        <Class IRI="#Sensing_Glove"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Playstation"/>
        <Class IRI="#HostDevice"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Playstation_VR_Headset"/>
        <Class IRI="#Types"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pneumonia"/>
        <Class IRI="#Complication"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Poor_Nutritional_Status"/>
        <Class IRI="#Prestroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Porcine_Ischemic_Stroke_Model"/>
        <Class IRI="#Model_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Post_Stroke_Comorbidity"/>
        <Class IRI="#Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Poststroke_Hyperglycemia"/>
        <Class IRI="#Post_Stroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Posttranscriptional_Gene_Silencing"/>
        <Class IRI="#Ischemic_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Prestroke_Comorbidity"/>
        <Class IRI="#Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Primary_Hypercholesteremia"/>
        <Class IRI="#Hypercholesteremia"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Primary_Hypertriglyceridemia"/>
        <Class IRI="#Hypertriglyceridemia"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Primary_Prevention_of_Stroke"/>
        <Class IRI="#Stroke_Prevention"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Prior_Stroke"/>
        <Class IRI="#Prestroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Process_Acceleration_Card"/>
        <Class IRI="#Hardware"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Prognosis"/>
        <Class IRI="#Evaluation_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Proximity_Sensor"/>
        <Class IRI="#Technologies"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Pulmonary_Embolism"/>
        <Class IRI="#Complication"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Race"/>
        <Class IRI="#Nonmodifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Renal_Dysfunction"/>
        <Class IRI="#Prestroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Risk_Factor"/>
        <Class IRI="#Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Risk_Factor_Reduction"/>
        <Class IRI="#Primary_Prevention_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Samsung_VR_Headset"/>
        <Class IRI="#Types"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Scales"/>
        <Class IRI="#Evaluation_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Screening_for_Diabetic_Mellitus"/>
        <Class IRI="#Secondary_Prevention_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Screening_for_Sleep_Apnea"/>
        <Class IRI="#Primary_Prevention_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Secondary_Hypercholesteremia"/>
        <Class IRI="#Hypercholesteremia"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Secondary_Hyperlipidemia"/>
        <Class IRI="#Hyperlipidaemia"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Secondary_Hypertriglyceridemia"/>
        <Class IRI="#Hypertriglyceridemia"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Secondary_Prevention_of_Stroke"/>
        <Class IRI="#Stroke_Prevention"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Self_Monitoring_of_Blood_Pressure"/>
        <Class IRI="#Primary_Prevention_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Semantic_Model_of_Stroke"/>
        <Class IRI="#Model_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Semi_Immersive"/>
        <Class IRI="#Technology"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Sensing_Glove"/>
        <Class IRI="#Input/Output_Devices"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Sensory_Displays"/>
        <Class IRI="#Hardware"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Sensory_Feedback"/>
        <Class IRI="#Component"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Shoulder_Pain"/>
        <Class IRI="#Post_Stroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Shwartz_Index"/>
        <Class IRI="#Measures_of_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Simulation_Software"/>
        <Class IRI="#Software"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Smartphone"/>
        <Class IRI="#HostDevice"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Smoking"/>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Snoring"/>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Software"/>
        <Class IRI="#Virtual_Reality"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Strain_Gauges"/>
        <Class IRI="#Sensing_Glove"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stroke"/>
        <Class abbreviatedIRI="owl:Thing"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stroke_Center"/>
        <Class IRI="#General_Treatment_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stroke_Mimics"/>
        <Class IRI="#Differential_Diagnosis_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stroke_Prevention"/>
        <Class IRI="#Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stroke_Type"/>
        <Class IRI="#Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Stroke_team"/>
        <Class IRI="#Evaluation_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Subarachnoid_Hemorrhage"/>
        <Class IRI="#Intracranial_Hemorrhage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Symptom_of_Hemorrhagic_Stroke"/>
        <Class IRI="#Intracranial_Hemorrhage"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Symptom_of_Ischemic_Stroke"/>
        <Class IRI="#Ischemic_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Technologies"/>
        <Class IRI="#Headset"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Technology"/>
        <Class IRI="#Virtual_Reality"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Telemedicine"/>
        <Class IRI="#Evaluation_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Telestroke"/>
        <Class IRI="#Evaluation_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Temperature_Control"/>
        <Class IRI="#General_Treatment_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Tobacco_Use"/>
        <Class IRI="#Modifiable_Risk_Factors"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Tracking_Pad"/>
        <Class IRI="#Input/Output_Devices"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Tracking_System"/>
        <Class IRI="#Hardware"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Training"/>
        <Class IRI="#Application"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Treadmills"/>
        <Class IRI="#Input/Output_Devices"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Treatment"/>
        <Class IRI="#Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Treatment_of_Hemorrhagic_Stroke"/>
        <Class IRI="#Treatment"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Treatment_of_Ischemic_Stroke"/>
        <Class IRI="#Treatment"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Treatment_of_Pain_and_Anxiety"/>
        <Class IRI="#General_Treatment_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Type_2_Diabetes_Mellitus"/>
        <Class IRI="#Diabetes_Mellitus"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Types"/>
        <Class IRI="#Headset"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Urinary_Tract_Infection"/>
        <Class IRI="#Complication"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Virtual_World"/>
        <Class IRI="#Component"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Visual_Impairment"/>
        <Class IRI="#Post_Stroke_Comorbidity"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;"/>
        <Class IRI="#Diagnosis"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;Diagnostic_evaluation&apos;"/>
        <Class IRI="#Evaluation_of_Stroke"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;Jak-Stat_signaling_pathway&apos;"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;Mitogen-Activated_Protein_Kinase_Signaling_Pathway&apos;"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;Notch_signaling_pathway&apos;"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;Toll-like_receptor_signaling_pathway&apos;"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;angiopoietin_signaling_pathway&apos;"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;apoptotic_cell_death_pathway&apos;"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;brain-derived_neurotrophic_factor_signaling_pathway&apos;"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;c-Jun_N-terminal_kinases_MAPK_signaling_pathway&apos;"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;endoplasmic_reticulum_stress_-_the_unfolded_protein_response_pathway&apos;"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;homocysteine_metabolic_pathway&apos;"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;immune_response_pathway&apos;"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;inflammatory_response_pathway&apos;"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;lipid_metabolic_pathway&apos;"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;mTOR_signaling_pathway&apos;"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;necrosis_pathway&apos;"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;nuclear_factor_kappa_B_signaling_pathway&apos;"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;oxidative_stress_response_pathway&apos;"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;p38_MAPK_signaling_pathway&apos;"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;phosphatidylinositol_3-kinase-Akt_signaling_pathway&apos;"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#&apos;retinoic_acid_signaling_pathway&apos;"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#2D_Graphics_Software"/>
        <Class IRI="#Software"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#3D_Modelling_Software"/>
        <Class IRI="#Software"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Input/Output_Devices"/>
        <Class IRI="#Devices"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#chemokine_(C-C_motif)_ligand_2_signaling_pathway"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#nuclear_factor,_erythroid_2_like_2_signaling_pathway"/>
        <Class IRI="#Pathway"/>
    </SubClassOf>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Abdominal_Obesity</IRI>
        <Literal>Abdominal Obesity</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Accelerometer</IRI>
        <Literal>An accelerometer is an electronic sensor that measures the acceleration forces acting on an object, in order to determine the object&apos;s position in space and monitor&apos;s the object movement.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Accelerometer</IRI>
        <Literal>Accelerometer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Acute_Myocardial_Infarction</IRI>
        <Literal>MI</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Acute_Myocardial_Infarction</IRI>
        <Literal>Acute Myocardial Infarction</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Adjusted_Clinical_Group</IRI>
        <Literal>ACGs were originally developed to predict ambulatory care visits among patients of health maintenance organizations but have since been widely used to describe the extent of medical problems and their likely effects on health care resource use. Each ICD-9-CM code for a patient is assigned to 1 of 32 mutually exclusive adjusted diagnosis groups that groups diagnoses based on their similarity on a number of characteristics including expected persistence of the condition, likelihood of requiring hospitalization, or need for specialty referral.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Adjusted_Clinical_Group</IRI>
        <Literal>Berlowitz, D. R., Hoenig, H., Cowper, D. C., Duncan, P. W., &amp; Vogel, W. B. (2008). Impact of comorbidities on stroke rehabilitation outcomes: does the method matter?. Archives of physical medicine and rehabilitation, 89(10), 1903-1906.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Adjusted_Clinical_Group</IRI>
        <Literal>ACG</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Adjusted_Clinical_Group</IRI>
        <Literal>ACGs</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Adjusted_Clinical_Group</IRI>
        <Literal>Adjusted Clinical Group</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Age_Factor</IRI>
        <Literal>Age Factors</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Age_Factor</IRI>
        <Literal>Older Age</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Age_Factor</IRI>
        <Literal>Age Factor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Airway_Breathing_Circulation_Control</IRI>
        <Literal>ABCs</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Airway_Breathing_Circulation_Control</IRI>
        <Literal>Airway Breathing Circulation Control</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Anemia</IRI>
        <Literal>Robert Bhler, Heinrich P. Mattle, Chapter 45 Hematological diseases and stroke, Handbook of Clinical Neurology, Elsevier, 2008, Volume 93, Pages 887-934</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Anemia</IRI>
        <Literal>http://www.uptodate.com/contents/ischemic-stroke-prognosis-in-adults</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Anemia</IRI>
        <Literal>Anemias</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Anemia</IRI>
        <Literal>Anemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Angioplasty</IRI>
        <Literal>Balloon angioplasty with or without stent placement represents a different approach to the recanalization of arterial occlusion. This strategy, which is similar to the approach commonly taken in patients with acute myocardial infarction, was hampered for a long time by the absence of dedicated catheters for the cerebral vasculature.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Angioplasty</IRI>
        <Literal>Cohen, J. E., Itshayek, E., Moskovici, S., Gomori, J. M., Fraifeld, S., Eichel, R., &amp; Leker, R. R. (2011). State-of-the-art reperfusion strategies for acute ischemic stroke. Journal of clinical neuroscience, 18(3), 319-323.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Angioplasty</IRI>
        <Literal>Angioplasty and Stenting</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Angioplasty</IRI>
        <Literal>Balloon Angioplasty</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Angioplasty</IRI>
        <Literal>Endovascular Angioplasty and Stenting</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Angioplasty</IRI>
        <Literal>Angioplasty</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Animal_Model_of_Stroke</IRI>
        <Literal>The use of animal models in recent years has provided a better understanding of the pathophysiologic mechanisms of strokes. Numerous animal species have been used to study strokes. Mice and rats are the most commonly used species, with a growing use of larger species, such as rabbits and even nonhuman primates, to better study the disease and its treatments.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Animal_Model_of_Stroke</IRI>
        <Literal>Casals, J. B., Pieri, N. C., Feitosa, M. L., Ercolin, A. C., Roballo, K. C., Barreto, R. S.,  Ambrsio, C. E. (2011). The Use of Animal Models for Stroke Research: A Review. Comparative Medicine, 61(4), 305313.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Animal_Model_of_Stroke</IRI>
        <Literal>Animal Models of Ischemic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Animal_Model_of_Stroke</IRI>
        <Literal>Animal Model of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Anticoagulation_Drugs_Therapy</IRI>
        <Literal>Anticoagulant therapy for acute stroke may only be considered after a brain imaging study has excluded hemorrhage and estimated the size of the infarct. Early anticoagulation should be avoided when potential contraindications to anticoagulation are present, such as a large infarction (based upon clinical syndrome or brain imaging findings), uncontrolled hypertension, or other bleeding conditions.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Anticoagulation_Drugs_Therapy</IRI>
        <Literal>Shahpouri, M. M., Mousavi, S., Khorvash, F., Mousavi, S. M., &amp; Hoseini, T. (2012). Anticoagulant therapy for ischemic stroke: A review of literature. Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences, 17(4), 396401.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Anticoagulation_Drugs_Therapy</IRI>
        <Literal>Anticoagulant</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Anticoagulation_Drugs_Therapy</IRI>
        <Literal>Anticoagulants</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Anticoagulation_Drugs_Therapy</IRI>
        <Literal>Anticoagulation Agents</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Anticoagulation_Drugs_Therapy</IRI>
        <Literal>Anticoagulation Drugs</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Anticoagulation_Drugs_Therapy</IRI>
        <Literal>Anticoagulation Drugs Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Antihypertensive_Drugs_Therapy</IRI>
        <Literal>Blood Pressure Medication</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Antihypertensive_Drugs_Therapy</IRI>
        <Literal>Vasopressor Drugs Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Antihypertensive_Drugs_Therapy</IRI>
        <Literal>Antihypertensive Drugs Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Antioxidants</IRI>
        <Literal>Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Antioxidants</IRI>
        <Literal>Antioxidants</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Antiplatelet_Drugs_Therapy</IRI>
        <Literal>Antiplatelet Agent</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Antiplatelet_Drugs_Therapy</IRI>
        <Literal>Antiplatelet Drugs</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Antiplatelet_Drugs_Therapy</IRI>
        <Literal>Antiplatelet Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Antiplatelet_Drugs_Therapy</IRI>
        <Literal>Antithrombotic Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Antiplatelet_Drugs_Therapy</IRI>
        <Literal>Antithrombotic Treatment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Antiplatelet_Drugs_Therapy</IRI>
        <Literal>Platelet Antagonists</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Antiplatelet_Drugs_Therapy</IRI>
        <Literal>Thromboprophylactic</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Antiplatelet_Drugs_Therapy</IRI>
        <Literal>Thromboprophylaxis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Antiplatelet_Drugs_Therapy</IRI>
        <Literal>Antiplatelet Drugs Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Aplastic_Anemia</IRI>
        <Literal>Aplastic Anemias</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Aplastic_Anemia</IRI>
        <Literal>Aplastic Anemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Arrhythmia</IRI>
        <Literal>Any cardiac rhythm other than the normal sinus rhythm. Such a rhythm may be either of sinus or ectopic origin and either regular or irregular. An arrhythmia may be due to a disturbance in impulse formation or conduction or both.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Arrhythmia</IRI>
        <Literal>Ostwald, S. K., Wasserman, J., &amp; Davis, S. (2006). Medications, comorbidities, and medical complications in stroke survivors: the CAReS study. Rehabilitation Nursing, 31(1), 10-14.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Arrhythmia</IRI>
        <Literal>Arrhythmias</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Arrhythmia</IRI>
        <Literal>Arrhythmia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Arterial_Circulation</IRI>
        <Literal>Arterial Circulation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Arteriovenous_Malformation</IRI>
        <Literal>Arteriovenous malformation (AVM) is an abnormal connection between arteries and veins, bypassing the capillary system. This vascular anomaly is widely known because of its occurrence in the central nervous system, but can appear in any location. Although many AVMs are asymptomatic, they can cause intense pain or bleeding or lead to other serious medical problems.
AVMs are usually congenital and belong to the RASopathies. The genetic transmission patterns of AVM, if any, are unknown. AVM is not generally thought to be an inherited disorder, unless in the context of a specific hereditary syndrome.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Arteriovenous_Malformation</IRI>
        <Literal>Arteriovenous malformation. wikipedia. Available from: https://en.wikipedia.org/wiki/Arteriovenous_malformation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Arteriovenous_Malformation</IRI>
        <Literal>AVM</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Arteriovenous_Malformation</IRI>
        <Literal>AVMs</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Arteriovenous_Malformation</IRI>
        <Literal>Arteriovenous Malformations</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Arteriovenous_Malformation</IRI>
        <Literal>Ruptured Arteriovenous Malformation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Arteriovenous_Malformation</IRI>
        <Literal>Arteriovenous Malformation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Automotive</IRI>
        <Literal>In automotive designs engineers are able to experience the look and feel of a car without building multiples prototypes. Safety trials can also be conducted by imitating the outside environment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Automotive</IRI>
        <Literal>Automotive</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Binge_Alcohol_Drinking</IRI>
        <Literal>Drinking an excessive amount of ALCOHOLIC BEVERAGES in a short period of time.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Binge_Alcohol_Drinking</IRI>
        <Literal>Alcohol Abuse</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Binge_Alcohol_Drinking</IRI>
        <Literal>Alcohol Binge</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Binge_Alcohol_Drinking</IRI>
        <Literal>Binge Drinking</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Binge_Alcohol_Drinking</IRI>
        <Literal>Drinking Binge</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Binge_Alcohol_Drinking</IRI>
        <Literal>Ethanol</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Binge_Alcohol_Drinking</IRI>
        <Literal>Ethanol Abuse</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Binge_Alcohol_Drinking</IRI>
        <Literal>Binge Alcohol Drinking</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Blood_Pressure_Control</IRI>
        <Literal>Blood Pressure Control</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Blood_Sugar_Control</IRI>
        <Literal>Blood Glucose Control</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Blood_Sugar_Control</IRI>
        <Literal>Blood Sugar Control</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Body_Suit</IRI>
        <Literal>The virtual reality suit is a wearable device that allows one to dive into a virtual reality world. Such a suit isolates the human body from the external world.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Body_Suit</IRI>
        <Literal>Gaming Suit</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Body_Suit</IRI>
        <Literal>Haptic Suit</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Body_Suit</IRI>
        <Literal>Tactile Suit</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Body_Suit</IRI>
        <Literal>Body Suit</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Brain_Anatomy</IRI>
        <Literal>Caplan LR. Caplan&apos;s stroke: a clinical approach: Elsevier Health Sciences; 2009</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Brain_Anatomy</IRI>
        <Literal>Brain Anatomy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Brain_Region</IRI>
        <Literal>Brain Region</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Cardiac_Arrest</IRI>
        <Literal>Cardiac Arrest</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Cardiac_Imaging_Biomarkers_of_Stroke</IRI>
        <Literal>Cardiac imaging is used to investigate risk factors and to search for a cardioembolic mechanism.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Cardiac_Imaging_Biomarkers_of_Stroke</IRI>
        <Literal>Maas, M. B., &amp; Furie, K. L. (2009). Molecular biomarkers in stroke diagnosis and prognosis. Biomarkers in medicine, 3(4), 363-383.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Cardiac_Imaging_Biomarkers_of_Stroke</IRI>
        <Literal>Cardiac Imaging Biomarkers of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Cardiac_Monitoring</IRI>
        <Literal>Cardiac Monitoring</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Cardiac_Related_Comorbidity</IRI>
        <Literal>Cardiac related comorbidities are the stroke comorbidities including arrhythmias, faulty heart valves, and coronary artery disease.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Cardiac_Related_Comorbidity</IRI>
        <Literal>Ostwald, S. K., Wasserman, J., &amp; Davis, S. (2006). Medications, comorbidities, and medical complications in stroke survivors: the CAReS study. Rehabilitation Nursing, 31(1), 10-14.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cardiac_Related_Comorbidity</IRI>
        <Literal>Cardiac Related Comorbidities</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Cardiac_Related_Comorbidity</IRI>
        <Literal>Cardiac Related Comorbidity</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Cardiac_Risk_Factor</IRI>
        <Literal>Akopov, S., &amp; Cohen, S. N. (2003). Preventing stroke: a review of current guidelines. Journal of the American Medical Directors Association, 4(5), S127-S132.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cardiac_Risk_Factor</IRI>
        <Literal>Cardiac Disease Risk Factor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cardiac_Risk_Factor</IRI>
        <Literal>Heart Disease Risk Factor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Cardiac_Risk_Factor</IRI>
        <Literal>Cardiac Risk Factor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carotid_Artery_Stenosis</IRI>
        <Literal>Asymptomatic Carotid Artery Stenosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carotid_Artery_Stenosis</IRI>
        <Literal>Asymptomatic Carotid Stenosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carotid_Artery_Stenosis</IRI>
        <Literal>Carotid Stenosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Carotid_Artery_Stenosis</IRI>
        <Literal>Carotid Artery Stenosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Carotid_Endarterectomy</IRI>
        <Literal>Carotid endarterectomy is a surgical procedure to unblock a carotid artery. Carotid endarterectomy is the most frequently performed noncardiac vascular procedure. Recent randomized prospective clinical trials have clearly showed that carotid endarterectomy is a highly beneficial treatment modality compared with the best medical treatment for patients with hemispheric and retinal TIAs or nondisabling strokes and ipsilateral high-grade stenosis of the internal carotid artery.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Carotid_Endarterectomy</IRI>
        <Literal>Biller, J., Feinberg, W. M., Castaldo, J. E., Whittemore, A. D., Harbaugh, R. E., Dempsey, R. J., ... &amp; Easton, J. D. (1998). Guidelines for Carotid Endarterectomy A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke, 29(2), 554-562.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carotid_Endarterectomy</IRI>
        <Literal>CEA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Carotid_Endarterectomy</IRI>
        <Literal>Carotid Endarterectomy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carotid_Revascularization</IRI>
        <Literal>Endovascular Revascularization</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Carotid_Revascularization</IRI>
        <Literal>Revascularization</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Carotid_Revascularization</IRI>
        <Literal>Carotid Revascularization</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Cell_Culture_Model_of_Stroke</IRI>
        <Literal>cell culture models have been developed to study mechanistic aspects of cerebral ischemia. These include monolayer cell cultures and three-dimensional cultures such as aggregated brain cells and brain tissue slices.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Cell_Culture_Model_of_Stroke</IRI>
        <Literal>Honegger, P., &amp; Pardo, B. (2007). Aggregating brain cell cultures: Investigation of stroke related brain damage. ALTEX, 24, 32-34.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cell_Culture_Model_of_Stroke</IRI>
        <Literal>Cell Culture Models of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Cell_Culture_Model_of_Stroke</IRI>
        <Literal>Cell Culture Model of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Cerebral_Aneurysm</IRI>
        <Literal>Outpouching of BASILAR ARTERY at the base of the skull. The basilar artery is the most important artery in the posterior cerebral circulation. Abnormal outpouching in the wall of intracranial blood vessels. Most common are the saccular (berry) aneurysms located at branch points in CIRCLE OF WILLIS at the base of the brain. Vessel rupture results in SUBARACHNOID HEMORRHAGE or INTRACRANIAL HEMORRHAGES. Giant aneurysms (&gt;2.5 cm in diameter) may compress adjacent structures, including the OCULOMOTOR NERVE. (From Adams et al., Principles of Neurology, 6th ed, p841)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Cerebral_Aneurysm</IRI>
        <Literal>http://purl.bioontology.org/ontology/MESH/D002532</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cerebral_Aneurysm</IRI>
        <Literal>Cerebral Aneurysms</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cerebral_Aneurysm</IRI>
        <Literal>Intracranial Aneurysm</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Cerebral_Aneurysm</IRI>
        <Literal>Cerebral Aneurysm</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Charlson_Comorbidity_Index</IRI>
        <Literal>The Charlson Comorbidity Index (CCI) has been validated for ischaemic stroke outcome studies. However, it was originally developed for patients in acute hospital settings, and it focused on mortality, not functional impairment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Charlson_Comorbidity_Index</IRI>
        <Literal>Karatepe, A. G., Gunaydin, R., Kaya, T., &amp; Turkmen, G. (2008). Comorbidity in patients after stroke: impact on functional outcome. Journal of rehabilitation medicine, 40(10), 831-835.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Charlson_Comorbidity_Index</IRI>
        <Literal>CCI</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Charlson_Comorbidity_Index</IRI>
        <Literal>Charlson Comorbidity Index</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Chronic_Blood_Transfusion</IRI>
        <Literal>For patients with sickle cell disease and prior ischemic stroke or TIA, chronic blood transfusions to reduce hemoglobin S to &lt;30% of total hemoglobin are recommended.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Chronic_Blood_Transfusion</IRI>
        <Literal>Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., ... &amp; Johnston, S. C. C. (2014). Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 45(7), 2160-2236.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Chronic_Blood_Transfusion</IRI>
        <Literal>Chronic Blood Transfusions</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Chronic_Blood_Transfusion</IRI>
        <Literal>Chronic Blood Transfusion</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Chronic_Kidney_Insufficiency</IRI>
        <Literal>CKD</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Chronic_Kidney_Insufficiency</IRI>
        <Literal>Chronic Kidney Disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Chronic_Kidney_Insufficiency</IRI>
        <Literal>Chronic Kidney Insufficiency</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Comorbidity</IRI>
        <Literal>The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Comorbidity</IRI>
        <Literal>Comorbidity</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Comorbidity_Severity_Index</IRI>
        <Literal>Comorbodity Severity Index</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Complication</IRI>
        <Literal>Medical complications of acute ischemic stroke are common and influence outcome after ischemic stroke.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Complication</IRI>
        <Literal>https://www.uptodate.com/contents/medical-complications-of-stroke?source=see_link</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Complication</IRI>
        <Literal>Complication of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Complication</IRI>
        <Literal>Stroke Complications</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Complication</IRI>
        <Literal>Complication</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Computer</IRI>
        <Literal>A standard personal computer can be equipped to run simple virtual environments.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Computer</IRI>
        <Literal>Computer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Computer_Model_of_Stroke</IRI>
        <Literal>Computer modeling tools developed to explain the process of early development of sensory systems can be extended to help us relate cortical plasticity to both behavior and to underlying molecular and cellular mechanisms.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Computer_Model_of_Stroke</IRI>
        <Literal>Lytton, W. W., Stark, J. M., Yamasaki, D. S., &amp; Sober, S. J. (1999).  REVIEW: Computer Models of Stroke Recovery: Implications for Neurorehabilitation. The Neuroscientist, 5(2), 100-111.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Computer_Model_of_Stroke</IRI>
        <Literal>Computer Models of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Computer_Model_of_Stroke</IRI>
        <Literal>Computer Model of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Congestive_Heart_Failure</IRI>
        <Literal>CHF</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Congestive_Heart_Failure</IRI>
        <Literal>Congestive Cardiac Failure</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Congestive_Heart_Failure</IRI>
        <Literal>Congestive Heart Failure</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Constipation</IRI>
        <Literal>Constipation is recognized as a serious problem in clinical practice, affecting 60% of those in stroke rehabilitation wards.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Constipation</IRI>
        <Literal>Harari, D., Norton, C., Lockwood, L., &amp; Swift, C. (2004). Treatment of constipation and fecal incontinence in stroke patients randomized controlled trial. Stroke, 35(11), 2549-2555.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Constipation</IRI>
        <Literal>Karatepe, A. G., Gunaydin, R., Kaya, T., &amp; Turkmen, G. (2008). Comorbidity in patients after stroke: impact on functional outcome. Journal of rehabilitation medicine, 40(10), 831-835.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Constipation</IRI>
        <Literal>Constipation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Coronary_Artery_Disease</IRI>
        <Literal>Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Thickening and loss of elasticity of the CORONARY ARTERIES, leading to progressive arterial insufficiency (CORONARY DISEASE).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Coronary_Artery_Disease</IRI>
        <Literal>Ostwald, S. K., Wasserman, J., &amp; Davis, S. (2006). Medications, comorbidities, and medical complications in stroke survivors: the CAReS study. Rehabilitation Nursing, 31(1), 10-14.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Coronary_Artery_Disease</IRI>
        <Literal>CAD</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Coronary_Artery_Disease</IRI>
        <Literal>Coronary Arteriosclerosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Coronary_Artery_Disease</IRI>
        <Literal>IHD</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Coronary_Artery_Disease</IRI>
        <Literal>Ischemic Heart Diseases</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Coronary_Artery_Disease</IRI>
        <Literal>Coronary Artery Disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Coronary_Heart_Disease</IRI>
        <Literal>An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Coronary_Heart_Disease</IRI>
        <Literal>CHD</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Coronary_Heart_Disease</IRI>
        <Literal>Coronary Heart Disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Cryptogenic_Stroke</IRI>
        <Literal>Cryptogenic stroke refers to stroke of unknown etiology and accounts for approximately 1540% of all ischemic strokes.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Cryptogenic_Stroke</IRI>
        <Literal>Zhang, C., &amp; Kasner, S. (2016). Diagnosis, prognosis, and management of cryptogenic stroke. F1000Research, 5, F1000 Faculty Rev168. http://doi.org/10.12688/f1000research.7384.1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Cryptogenic_Stroke</IRI>
        <Literal>Cryptogenic Strokes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Cryptogenic_Stroke</IRI>
        <Literal>Cryptogenic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Cumulative_Illness_Rating_Scale</IRI>
        <Literal>Cumulative Illness Rating Scale</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Damentia</IRI>
        <Literal>Yew, K. S., &amp; Cheng, E. (2009). Acute Stroke Diagnosis. American Family Physician, 80(1), 3340.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Damentia</IRI>
        <Literal>http://www.uptodate.com/contents/ischemic-stroke-prognosis-in-adults</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Damentia</IRI>
        <Literal>Damentia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Deep_Venous_Thrombosis</IRI>
        <Literal>Deep-vein thrombosis (DVT) is a common condition that can lead to complications such as postphlebitic syndrome, pulmonary embolism and death.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Deep_Venous_Thrombosis</IRI>
        <Literal>Scarvelis, D., &amp; Wells, P. S. (2006). Diagnosis and treatment of deep-vein thrombosis. Canadian Medical Association Journal, 175(9), 1087-1092.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Deep_Venous_Thrombosis</IRI>
        <Literal>https://www.uptodate.com/contents/medical-complications-of-stroke?source=see_link#H14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Deep_Venous_Thrombosis</IRI>
        <Literal>DVT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Deep_Venous_Thrombosis</IRI>
        <Literal>Deep Vein Thrombosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Deep_Venous_Thrombosis</IRI>
        <Literal>Deep Venous Thrombosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Dehydration</IRI>
        <Literal>The condition that results from excessive loss of water from a living organism.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dehydration</IRI>
        <Literal>Water Stress</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Dehydration</IRI>
        <Literal>Dehydration</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Depression</IRI>
        <Literal>An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Depression</IRI>
        <Literal>Karatepe, A. G., Gunaydin, R., Kaya, T., &amp; Turkmen, G. (2008). Comorbidity in patients after stroke: impact on functional outcome. Journal of rehabilitation medicine, 40(10), 831-835.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Depression</IRI>
        <Literal>http://purl.bioontology.org/ontology/SNOMEDCT/35489007</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Depression</IRI>
        <Literal>Depressive Disorder</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Depression</IRI>
        <Literal>Depressive Disorders</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Depression</IRI>
        <Literal>Depression</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Device_Control_Button</IRI>
        <Literal>The device control buttons help you to register your hand and finger movements in a virtual world. They turn your physical, kind of mechanic movements of your hands or body into a digital movements inside your chosen virtual world.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Device_Control_Button</IRI>
        <Literal>Controller</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Device_Control_Button</IRI>
        <Literal>Device Control Button</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Diabetes_Mellitus</IRI>
        <Literal>A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Diabetes_Mellitus</IRI>
        <Literal>Gorelick, P. B., &amp; Alter, M. (2002). The prevention of stroke. Peterson&apos;s.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Diabetes_Mellitus</IRI>
        <Literal>http://purl.bioontology.org/ontology/MESH/D003920</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diabetes_Mellitus</IRI>
        <Literal>DM</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diabetes_Mellitus</IRI>
        <Literal>Diabetes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Diabetes_Mellitus</IRI>
        <Literal>Diabetes Mellitus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Diagnosis</IRI>
        <Literal>Diagnosis of a disease or condition made before DEATH. The determination of the nature of a disease or condition, or the distinguishing of one disease or condition from another. Assessment may be made through physical examination, laboratory tests, or the likes. Computerized programs may be used to enhance the decision-making process. Diagnosis of a disease or condition made after DEATH.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Diagnosis</IRI>
        <Literal>http://purl.bioontology.org/ontology/MESH/D003933</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diagnosis</IRI>
        <Literal>Diagnosed</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diagnosis</IRI>
        <Literal>Diagnostic</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diagnosis</IRI>
        <Literal>Dx</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Diagnosis</IRI>
        <Literal>Diagnosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Diagnosis_Cost_Group</IRI>
        <Literal>DCGs were originally developed to predict future costs for Medicare beneficiaries. Each ICD-9-CM code is first grouped into diagnostic clusters of clinically related disorders. Clusters are subsequently grouped into hierarchical condition categories that consider the severity and expected costliness of related disorders. Examples of hierarchies are congestive heart failure and diabetes mellitus with chronic complications. Hierarchies may be further clustered into aggregated condition categories.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Diagnosis_Cost_Group</IRI>
        <Literal>Berlowitz, D. R., Hoenig, H., Cowper, D. C., Duncan, P. W., &amp; Vogel, W. B. (2008). Impact of comorbidities on stroke rehabilitation outcomes: does the method matter?. Archives of physical medicine and rehabilitation, 89(10), 1903-1906.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diagnosis_Cost_Group</IRI>
        <Literal>DCG</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Diagnosis_Cost_Group</IRI>
        <Literal>DCGs</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Diagnosis_Cost_Group</IRI>
        <Literal>Diagnosis Cost Group</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Dietary_Factor</IRI>
        <Literal>The consideration of dietary factors as a variable in disease incident, transmission, and control.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Dietary_Factor</IRI>
        <Literal>http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C18744</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dietary_Factor</IRI>
        <Literal>Diet</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dietary_Factor</IRI>
        <Literal>Dietary Factors</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dietary_Factor</IRI>
        <Literal>Diets</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dietary_Factor</IRI>
        <Literal>Nutritional Factors</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Dietary_Factor</IRI>
        <Literal>Dietary Factor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dietary_Habit</IRI>
        <Literal>Dietary Habits</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dietary_Habit</IRI>
        <Literal>Food Habit</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Dietary_Habit</IRI>
        <Literal>Dietary habit</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Differential_Diagnosis_of_Stroke</IRI>
        <Literal>Differential diagnosis refers to the process of differentiating one diagnosis from another, and in turn, providing the most fitting diagnosis based on an individuals presentation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Differential_Diagnosis_of_Stroke</IRI>
        <Literal>Bullard, S. E., Griss, M., Greene, S., &amp; Gekker, A. (2012). Encyclopedia of Clinical Neuropsychology. Archives of Clinical Neuropsychology, acs103.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Differential_Diagnosis_of_Stroke</IRI>
        <Literal>DDx of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Differential_Diagnosis_of_Stroke</IRI>
        <Literal>Differential Diagnosis of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Drug_Abuse</IRI>
        <Literal>Medication Abuse</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Drug_Abuse</IRI>
        <Literal>Sympathomimetic Agent</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Drug_Abuse</IRI>
        <Literal>Sympathomimetic Agents</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Drug_Abuse</IRI>
        <Literal>Drug Abuse</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Dural_Venous_Sinus</IRI>
        <Literal>Dural Venous Sinus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Dysphagia</IRI>
        <Literal>In the context of stroke, oropharyngeal dysphagia is probably best defined as a disruption of bolus flow through the mouth and pharynx.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Dysphagia</IRI>
        <Literal>ysphagia is a common complication of stroke and is a major risk factor for developing aspiration pneumonia.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Dysphagia</IRI>
        <Literal>Singh, S., &amp; Hamdy, S. (2006). Dysphagia in stroke patients. Postgraduate medical journal, 82(968), 383-391.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Dysphagia</IRI>
        <Literal>https://www.uptodate.com/contents/medical-complications-of-stroke?source=see_link#H51491951</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Dysphagia</IRI>
        <Literal>Swallowing Difficult</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Dysphagia</IRI>
        <Literal>Dysphagia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Education</IRI>
        <Literal>An important application area of application for virtual reality systems has always been training for real-life activities. The appeal of simulations is that they can provide training equal or nearly equal to practice with real systems, but at reduced cost and with greater safety</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Education</IRI>
        <Literal>Education</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Education_Prevention</IRI>
        <Literal>Education</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Education_Prevention</IRI>
        <Literal>Education Intervention</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Education_Prevention</IRI>
        <Literal>Education Prevention</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Electrocardiographic_Abnormality</IRI>
        <Literal>ECG Abnormalities</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Electrocardiographic_Abnormality</IRI>
        <Literal>ECG Abnormality</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Electrocardiographic_Abnormality</IRI>
        <Literal>EKG Abnormalities</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Electrocardiographic_Abnormality</IRI>
        <Literal>Electrocardiographic Abnormalities</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Electrocardiographic_Abnormality</IRI>
        <Literal>Repolarization Abnormalities</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Electrocardiographic_Abnormality</IRI>
        <Literal>Repolarization Abnormality</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Electrocardiographic_Abnormality</IRI>
        <Literal>Electrocardiographic Abnormality</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Electrophysiological_Biomarkers_of_Stroke</IRI>
        <Literal>Electrophysiology holds both practical and theoretical advantages as a clinical biomarker in neurodevelopmental disorders.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Electrophysiological_Biomarkers_of_Stroke</IRI>
        <Literal>Jeste, S. S., Frohlich, J., &amp; Loo, S. K. (2015). Electrophysiological biomarkers of diagnosis and outcome in neurodevelopmental disorders. Current opinion in neurology, 28(2), 110-116.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Electrophysiological_Biomarkers_of_Stroke</IRI>
        <Literal>Electrophysiological Biomarkers of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Electtrocardiographic_Abnormality</IRI>
        <Literal>ECG Abnormalities</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Electtrocardiographic_Abnormality</IRI>
        <Literal>ECG Abnormality</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Electtrocardiographic_Abnormality</IRI>
        <Literal>EKG Abnormalities</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Electtrocardiographic_Abnormality</IRI>
        <Literal>EKG Abnormality</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Electtrocardiographic_Abnormality</IRI>
        <Literal>Electrocardiographic Abnormalities</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Electtrocardiographic_Abnormality</IRI>
        <Literal>Repolarization Abnormalities</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Electtrocardiographic_Abnormality</IRI>
        <Literal>Repolarization Abnormality</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Electtrocardiographic_Abnormality</IRI>
        <Literal>Electrocardiographic Abnormality</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Elevated_Cardiac_Enzyme</IRI>
        <Literal>Elevated Cardiac Enzymes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Elevated_Cardiac_Enzyme</IRI>
        <Literal>Elevated Cardiac Enzyme</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Elevated_Cardiac_Troponin</IRI>
        <Literal>Elevated Cardiac Troponin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Endothelial_Dysfunction</IRI>
        <Literal>In vascular diseases, endothelial dysfunction is a systemic pathological state of the endothelium (the inner lining of blood vessels) and can be broadly defined as an imbalance between vasodilating and vasoconstricting substances produced by (or acting on) the endothelium. Normal functions of endothelial cells include mediation of coagulation, platelet adhesion, immune function and control of volume and electrolyte content of the intravascular and extravascular spaces. Endothelial dysfunction is a risk factor for cerebrovascular events.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Endothelial_Dysfunction</IRI>
        <Literal>Endothelial Dysfunction</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Estrogen_Replacement_Therapy</IRI>
        <Literal>The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Estrogen_Replacement_Therapy</IRI>
        <Literal>http://purl.bioontology.org/ontology/MESH/D015914</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Estrogen_Replacement_Therapy</IRI>
        <Literal>ERT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Estrogen_Replacement_Therapy</IRI>
        <Literal>Postmenopausal Hormone Replacement Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Estrogen_Replacement_Therapy</IRI>
        <Literal>Estrogen Replacement Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Etiology_of_Hemorrhagic_Stroke</IRI>
        <Literal>Stroke Etiology</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Etiology_of_Hemorrhagic_Stroke</IRI>
        <Literal>Etiology of Hemorrhagic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Etiology_of_Ischemic_Stroke</IRI>
        <Literal>Three basic mechanisms can result in cessation or diminution of f low to regions of brain: embolism from a proximal source with occlusion of the downstream artery; local occlusion, usually due to in situ thrombosis, of a proximal or distal artery; or global hypoperfusion.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Etiology_of_Ischemic_Stroke</IRI>
        <Literal>Harrigan, M. R., Ardelt, A., &amp; Deveikis, J. P. (2009). Handbook of cerebrovascular disease and neurointerventional technique. Springer Science &amp; Business Media.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Etiology_of_Ischemic_Stroke</IRI>
        <Literal>Mechanisms of Ischemic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Etiology_of_Ischemic_Stroke</IRI>
        <Literal>Stroke Etiology</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Etiology_of_Ischemic_Stroke</IRI>
        <Literal>Etiology of Ischemic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Evaluation_of_Stroke</IRI>
        <Literal>An overview of the evaluation of patients who present with neurologic symptoms that may be consistent with stroke includes the following:  understanding the classification of stroke, An initial quick evaluation to stabilize vital signs, determine if intracranial hemorrhage is present, and, in patients with ischemic stroke, decide if reperfusion therapy is warranted, Forming a hypothesis of the stroke etiology based upon the history, physical examination, and initial brain imaging study (usually a noncontrast head CT scan) and  Confirming the precise pathophysiologic process with more directed diagnostic testing.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Evaluation_of_Stroke</IRI>
        <Literal>http://www.uptodate.com/contents/overview-of-the-evaluation-of-stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Evaluation_of_Stroke</IRI>
        <Literal>Diagnostic Evaluation of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Evaluation_of_Stroke</IRI>
        <Literal>Stroke Evaluation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Evaluation_of_Stroke</IRI>
        <Literal>Evaluation of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Familial_Combined_Hyperlipidemias</IRI>
        <Literal>A type of familial lipid metabolism disorder characterized by a variable pattern of elevated plasma CHOLESTEROL and/or TRIGLYCERIDES. Multiple genes on different chromosomes may be involved, such as the major late transcription factor (UPSTREAM STIMULATORY FACTORS) on CHROMOSOME 1.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Familial_Combined_Hyperlipidemias</IRI>
        <Literal>Familial Combined Hyperlipidemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Familial_Combined_Hyperlipidemias</IRI>
        <Literal>Multiple Lipoprotein-Type Hyperlipidemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Familial_Combined_Hyperlipidemias</IRI>
        <Literal>Familial Combined Hyperlipidemias</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Familial_Hypertriglyceridemia</IRI>
        <Literal>Familial hypertriglyceridemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Family_History_of_stroke</IRI>
        <Literal>Family History of CVA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Family_History_of_stroke</IRI>
        <Literal>Family History of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Faulty_Heart_Valves</IRI>
        <Literal>Ostwald, S. K., Wasserman, J., &amp; Davis, S. (2006). Medications, comorbidities, and medical complications in stroke survivors: the CAReS study. Rehabilitation Nursing, 31(1), 10-14.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Faulty_Heart_Valves</IRI>
        <Literal>Faulty Heart Valves</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Fully_Immersive</IRI>
        <Literal>Fully immersive environment provides the most immersive execution of the technology where the user is fully immersed in the virtual world. It provide a realistic user experience by providing high resolutions, large viewer area, increased refresh rates and high contrast levels in HMDs.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Fully_Immersive</IRI>
        <Literal>Fully Immersive</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Functional_Comorbidity_Index</IRI>
        <Literal>The FCI was developed as a comorbidity index with physical function as the outcome of interest, using an 18-item (comorbidities) self-administered questionnaire where the FCI score is the sum of the number of conditions reported for the person (018).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Functional_Comorbidity_Index</IRI>
        <Literal>Gabbe, B. J., Harrison, J. E., Lyons, R. A., Edwards, E. R., &amp; Cameron, P. A. (2013). Comparison of measures of comorbidity for predicting disability 12-months post-injury. BMC Health Services Research, 13, 30. http://doi.org/10.1186/1472-6963-13-30</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Functional_Comorbidity_Index</IRI>
        <Literal>FCI</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Functional_Comorbidity_Index</IRI>
        <Literal>Functional Comorbidity Index</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Gaming</IRI>
        <Literal>Virtual reality gaming is where a person can experience being in a three-dimentional environment and interact with that environment during a game.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Gaming</IRI>
        <Literal>Gaming</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Gastritis</IRI>
        <Literal>Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Gastritis</IRI>
        <Literal>Karatepe, A. G., Gunaydin, R., Kaya, T., &amp; Turkmen, G. (2008). Comorbidity in patients after stroke: impact on functional outcome. Journal of rehabilitation medicine, 40(10), 831-835.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Gastritis</IRI>
        <Literal>http://purl.bioontology.org/ontology/MESH/D005756</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Gastritis</IRI>
        <Literal>Gastritis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Gastrointestinal_Bleeding</IRI>
        <Literal>https://www.uptodate.com/contents/medical-complications-of-stroke?source=see_link#H14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Gastrointestinal_Bleeding</IRI>
        <Literal>GI Bleeding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Gastrointestinal_Bleeding</IRI>
        <Literal>GIB</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Gastrointestinal_Bleeding</IRI>
        <Literal>Gastrointestinal Bleeding</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Gender</IRI>
        <Literal>Patient Sex</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Gender</IRI>
        <Literal>Sex</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Gender</IRI>
        <Literal>Sex Factors</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Gender</IRI>
        <Literal>Gender</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#General_Treatment_of_Stroke</IRI>
        <Literal>General Treatment of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Genetic_Risk_Factor</IRI>
        <Literal>Genetic</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Genetic_Risk_Factor</IRI>
        <Literal>Genetic Factors</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Genetic_Risk_Factor</IRI>
        <Literal>Heredity Factors</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Genetic_Risk_Factor</IRI>
        <Literal>Genetic Risk Factor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Geographic_Area</IRI>
        <Literal>Geographic Factor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Geographic_Area</IRI>
        <Literal>Geographic Factors</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Geographic_Area</IRI>
        <Literal>Geographic Area</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Gyroscope</IRI>
        <Literal>A gyroscope  is a device used for measuring or maintaining orientation and angular velocity. It is a spinning wheel or disc in which the axis of rotation (spin axis) is free to assume any orientation by itself.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Gyroscope</IRI>
        <Literal>Gyroscope</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Haptic_Feedback_System</IRI>
        <Literal>The haptic feedback system allows the user to touch and feel something in the virtual environment that is not in the real world.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Haptic_Feedback_System</IRI>
        <Literal>Haptic Feedback System</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Headsets</IRI>
        <Literal>The virtual reality headset is a head-mounted device that provides virtual reality for the wearer. The headset replace the user&apos;s natural environment with virtual reality content.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Headsets</IRI>
        <Literal>Headset</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Healthcare</IRI>
        <Literal>In the healthcare domain  virtual reality training was developed to provide a different channel for medical training and education for healthcare personnel so as to reduce cost and risks involved when undergoing the training physically. Among the virtual reality training includes; virtual surgery for laparoscopic, ophthalmology, endoscopic procedures, stroke rehabilitation, anatomy dissection, emergency simulation, and many more procedural trainings.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Healthcare</IRI>
        <Literal>Healthcare</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Heart_Failure</IRI>
        <Literal>Heart failure involving the LEFT VENTRICLE. Heart failure caused by dysfunction of the MYOCARDIUM, leading to defective cardiac emptying (contraction) or filling (relaxation). Heart failure involving the RIGHT VENTRICLE. A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Heart_Failure</IRI>
        <Literal>http://purl.bioontology.org/ontology/MESH/D006333</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Heart_Failure</IRI>
        <Literal>Lin, C. Y., Chien, C. C., Chen, H. A., Su, F. M., Wang, J. J., Wang, C. C., ... &amp; Lin, Y. J. (2014). The impact of comorbidity on survival after hemorrhagic stroke among dialysis patients: a nationwide population-based study. BMC nephrology, 15(1), 1.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Heart_Failure</IRI>
        <Literal>HF</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Heart_Failure</IRI>
        <Literal>Heart Failure</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hemostatic_Factor</IRI>
        <Literal>Haemostatic Factors</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Hemostatic_Factor</IRI>
        <Literal>Hemostatic Factor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Histological_Biomarkers_of_Stroke</IRI>
        <Literal>Histological markers can be especially useful in evaluating uncommon causes, such as vasculitis and collagen vascular diseases.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Histological_Biomarkers_of_Stroke</IRI>
        <Literal>Maas, M. B., &amp; Furie, K. L. (2009). Molecular biomarkers in stroke diagnosis and prognosis. Biomarkers in medicine, 3(4), 363-383.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Histological_Biomarkers_of_Stroke</IRI>
        <Literal>Histological Biomarkers of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#History_of_Recent_Infection</IRI>
        <Literal>History of Recent Infection</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Hypercholesteremia</IRI>
        <Literal>A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypercholesteremia</IRI>
        <Literal>Elevated Cholesterols</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypercholesteremia</IRI>
        <Literal>Elevated cholesterol</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypercholesteremia</IRI>
        <Literal>High Cholesterol Level</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypercholesteremia</IRI>
        <Literal>Hypercholesteremias</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Hypercholesteremia</IRI>
        <Literal>Hypercholesteremia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Hyperglycemia</IRI>
        <Literal>Hyperglycemia is common in patients with acute stroke, occurring in up to 60% of patients overall and approximately 12- 53% of acute stroke patients without a prior diagnosis of diabetes. Hyperglycaemia predicts higher mortality and morbidity after acute stroke independently of other adverse prognostic factors, such as older age, type and severity of stroke, and non-reversibility of the neurological deficit.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Hyperglycemia</IRI>
        <Literal>Badiger, S., Akkasaligar, P. T., &amp; Narone, U. (2013). Hyperglycemia and stroke. International Journal of Stroke Research, 1(1), 1-6.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Hyperglycemia</IRI>
        <Literal>High Blood Glucose</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Hyperglycemia</IRI>
        <Literal>High Blood Sugar</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Hyperglycemia</IRI>
        <Literal>Hyperglycemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Hyperlipidaemia</IRI>
        <Literal>Conditions with excess LIPIDS in the blood. Abnormally high level of lipids in blood.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Hyperlipidaemia</IRI>
        <Literal>Karatepe, A. G., Gunaydin, R., Kaya, T., &amp; Turkmen, G. (2008). Comorbidity in patients after stroke: impact on functional outcome. Journal of rehabilitation medicine, 40(10), 831-835.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipidaemia</IRI>
        <Literal>Hyperlipemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipidaemia</IRI>
        <Literal>Hyperlipemias</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipidaemia</IRI>
        <Literal>Hyperlipidemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipidaemia</IRI>
        <Literal>Hyperlipidemias</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipidaemia</IRI>
        <Literal>Lipemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipidaemia</IRI>
        <Literal>Lipemias</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipidaemia</IRI>
        <Literal>Lipidemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipidaemia</IRI>
        <Literal>Lipidemias</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Hyperlipidaemia</IRI>
        <Literal>Hyperlipidaemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipidemia_due_to_Type_2_Diabetes_Mellitus</IRI>
        <Literal>Hyperlipidemia due to T2DM</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Hyperlipidemia_due_to_Type_2_Diabetes_Mellitus</IRI>
        <Literal>Hyperlipidemia due to Type 2 Diabetes Mellitus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Hyperlipoproteinemia_Type_I</IRI>
        <Literal>An inherited condition due to a deficiency of either LIPOPROTEIN LIPASE or APOLIPOPROTEIN C-II (a lipase-activating protein). The lack of lipase activities results in inability to remove CHYLOMICRONS and TRIGLYCERIDES from the blood which has a creamy top layer after standing.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_I</IRI>
        <Literal>Apolipoprotein C II Deficiency</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_I</IRI>
        <Literal>Burger Grutz Syndrome</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_I</IRI>
        <Literal>Burger-Grutz Syndromes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_I</IRI>
        <Literal>C-II Anapolipoproteinemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_I</IRI>
        <Literal>C-II Anapolipoproteinemias</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_I</IRI>
        <Literal>Familial Chylomicronemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Hyperlipoproteinemia_Type_I</IRI>
        <Literal>Hyperlipoproteinemia Type I</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Hyperlipoproteinemia_Type_II</IRI>
        <Literal>Hypercholesterolemia that is caused by mutation in the LOW DENSITY LIPOPROTEIN RECEPTOR gene. This receptor defect prevents LDL binding to the cell membrane and uptake of cholesterol which normally suppresses further cholesterol synthesis. A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). Type IIb hyperlipoproteinemia is caused by mutation in the receptor-binding domain of APOLIPOPROTEIN B-100 which is a major component of LOW-DENSITY LIPOPROTEINS and VERY-LOW-DENSITY LIPOPROTEINS resulting in reduced clearance of these lipoproteins. It is characterized by both hypercholesterolemia and HYPERTRIGLYCERIDEMIA (combined hyperlipidemia).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_II</IRI>
        <Literal>Autosomal Dominant Hypercholesterolemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_II</IRI>
        <Literal>Essential Hypercholesterolemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_II</IRI>
        <Literal>Essential Hypercholesterolemias</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_II</IRI>
        <Literal>Familial Combined Hyperlipoproteinemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_II</IRI>
        <Literal>Familial Hypercholesterolemic Xanthomatoses</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_II</IRI>
        <Literal>Hyper Low Density Lipoproteinemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Hyperlipoproteinemia_Type_II</IRI>
        <Literal>Hyperlipoproteinemia Type II</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Hyperlipoproteinemia_Type_III</IRI>
        <Literal>An autosomal recessively inherited disorder characterized by the accumulation of intermediate-density lipoprotein (IDL or broad-beta-lipoprotein). IDL has a CHOLESTEROL to TRIGLYCERIDES ratio greater than that of VERY-LOW-DENSITY LIPOPROTEINS. This disorder is due to mutation of APOLIPOPROTEINS E, a receptor-binding component of VLDL and CHYLOMICRONS, resulting in their reduced clearance and high plasma levels of both cholesterol and triglycerides.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_III</IRI>
        <Literal>Broad Beta Disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_III</IRI>
        <Literal>Broad-beta Hyperlipoproteinemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_III</IRI>
        <Literal>Dysbetalipoproteinemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_III</IRI>
        <Literal>Familial Dysbetalipoproteinemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_III</IRI>
        <Literal>Type III Hyperlipoproteinemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_III</IRI>
        <Literal>Type III Hyperlipoproteinemias</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Hyperlipoproteinemia_Type_III</IRI>
        <Literal>Hyperlipoproteinemia Type III</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Hyperlipoproteinemia_Type_IV</IRI>
        <Literal>A hypertriglyceridemia disorder, often with autosomal dominant inheritance. It is characterized by the persistent elevations of plasma TRIGLYCERIDES, endogenously synthesized and contained predominantly in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). In contrast, the plasma CHOLESTEROL and PHOSPHOLIPIDS usually remain within normal limits.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_IV</IRI>
        <Literal>Carbohydrate Inducible Hyperlipemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_IV</IRI>
        <Literal>Familial Hyperlipoproteinemia Type 4</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_IV</IRI>
        <Literal>Familial Hypertriglyceridemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_IV</IRI>
        <Literal>Familial Type IV Hyperlipoproteinemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_IV</IRI>
        <Literal>Hyperprebetalipoproteinemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_IV</IRI>
        <Literal>Type IV Hyperlipoproteinemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Hyperlipoproteinemia_Type_IV</IRI>
        <Literal>Hyperlipoproteinemia Type IV</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Hyperlipoproteinemia_Type_V</IRI>
        <Literal>A severe type of hyperlipidemia, sometimes familial, that is characterized by the elevation of both plasma CHYLOMICRONS and TRIGLYCERIDES contained in VERY-LOW-DENSITY LIPOPROTEINS. Type V hyperlipoproteinemia is often associated with DIABETES MELLITUS and is not caused by reduced LIPOPROTEIN LIPASE activity as in HYPERLIPOPROTEINEMIA TYPE I .</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_V</IRI>
        <Literal>Hyperchylomicronemia Late Onset</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_V</IRI>
        <Literal>Hyperlipoproteinemia Type 5</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_V</IRI>
        <Literal>Late-Onset Hyperchylomicronemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_V</IRI>
        <Literal>Mixed Hyperlipemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemia_Type_V</IRI>
        <Literal>Type V Hyperlipoproteinemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Hyperlipoproteinemia_Type_V</IRI>
        <Literal>Hyperlipoproteinemia Type V</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Hyperlipoproteinemias</IRI>
        <Literal>Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinemias</IRI>
        <Literal>Hyperlipoproteinemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Hyperlipoproteinemias</IRI>
        <Literal>Hyperlipoproteinemias</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Hyperlipoproteinnemia_Type_IV</IRI>
        <Literal>A hypertriglyceridemia disorder, often with autosomal dominant inheritance. It is characterized by the persistent elevations of plasma TRIGLYCERIDES, endogenously synthesized and contained predominantly in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). In contrast, the plasma CHOLESTEROL and PHOSPHOLIPIDS usually remain within normal limits.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinnemia_Type_IV</IRI>
        <Literal>Carbohydrate Inducible Hyperlipemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinnemia_Type_IV</IRI>
        <Literal>Familial Hyperlipoproteinemia Type 4</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinnemia_Type_IV</IRI>
        <Literal>Familial Type IV Hyperlipoproteinemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinnemia_Type_IV</IRI>
        <Literal>Hyperprebetalipoproteinemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Hyperlipoproteinnemia_Type_IV</IRI>
        <Literal>Hyperlipoproteinemia Type IV</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Hyperlipoproteinnemia_Type_V</IRI>
        <Literal>A severe type of hyperlipidemia, sometimes familial, that is characterized by the elevation of both plasma CHYLOMICRONS and TRIGLYCERIDES contained in VERY-LOW-DENSITY LIPOPROTEINS. Type V hyperlipoproteinemia is often associated with DIABETES MELLITUS and is not caused by reduced LIPOPROTEIN LIPASE activity as in HYPERLIPOPROTEINEMIA TYPE I .</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinnemia_Type_V</IRI>
        <Literal>Hyperchylomicronemia Late Onset</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinnemia_Type_V</IRI>
        <Literal>Hyperlipoproteinemia Type 5</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinnemia_Type_V</IRI>
        <Literal>Late-Onset Hyperchylomicronemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hyperlipoproteinnemia_Type_V</IRI>
        <Literal>Type V Hyperlipidemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Hyperlipoproteinnemia_Type_V</IRI>
        <Literal>Hyperlipoproteinemia Type V</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Hyperruricemia</IRI>
        <Literal>Hyperuricemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Hypertension</IRI>
        <Literal>Hypertension is usually defined by the presence of a chronic elevation of systemic arterial pressure above a certain threshold value.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Hypertension</IRI>
        <Literal>Giles, T. D., Materson, B. J., Cohn, J. N., &amp; Kostis, J. B. (2009). Definition and Classification of Hypertension: An Update. The Journal of Clinical Hypertension, 11(11), 611-614. doi: 10.1111/j.1751-7176.2009.00179.x</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypertension</IRI>
        <Literal>HTN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypertension</IRI>
        <Literal>High Blood Pressure</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Hypertension</IRI>
        <Literal>Hypertension</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Hypertention</IRI>
        <Literal>Hypertension is usually defined by the presence of a chronic elevation of systemic arterial pressure above a certain threshold value.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Hypertention</IRI>
        <Literal>Giles, T. D., Materson, B. J., Cohn, J. N., &amp; Kostis, J. B. (2009). Definition and Classification of Hypertension: An Update. The Journal of Clinical Hypertension, 11(11), 611-614. doi: 10.1111/j.1751-7176.2009.00179.x</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypertention</IRI>
        <Literal>HTN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypertention</IRI>
        <Literal>High Blood Pressure</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Hypertention</IRI>
        <Literal>Hypertension</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Hypertriglyceridemia</IRI>
        <Literal>A condition of elevated levels of TRIGLYCERIDES in the blood.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypertriglyceridemia</IRI>
        <Literal>Elevated Triglycerides</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypertriglyceridemia</IRI>
        <Literal>Hypertriglyceridemias</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Hypertriglyceridemia</IRI>
        <Literal>Hypertriglyceridemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Hypoxemia</IRI>
        <Literal>Hypoxemias</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Hypoxemia</IRI>
        <Literal>Hypoxemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Immersion</IRI>
        <Literal>Immersion in a virtual environment means the perception of presence in a non physical or virtual world</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Immersion</IRI>
        <Literal>Immersion</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#In_Silico_Model_of_Stroke</IRI>
        <Literal>In silico modeling has proven to be a useful tool in biology because it allows the study of interspecies variation and regulation of homeostasis and allows the integration of information from various sources.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#In_Silico_Model_of_Stroke</IRI>
        <Literal>Van de Pas, N. C. A., Woutersen, R. A., van Ommen, B., Rietjens, I. M. C. M., &amp; de Graaf, A. A. (2012). A physiologically based in silico kinetic model predicting plasma cholesterol concentrations in humans. Journal of Lipid Research, 53(12), 27342746. http://doi.org/10.1194/jlr.M031930</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#In_Silico_Model_of_Stroke</IRI>
        <Literal>In Silico Model of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#In_Vitro_Model_of_Stroke</IRI>
        <Literal>Many in vitro brain endothelial cell culture models have been developed and studied over the past several decades to understand the pathophysiological mechanisms and role of the BBB in stroke.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#In_Vitro_Model_of_Stroke</IRI>
        <Literal>Yang, L., Shah, K. K., &amp; Abbruscato, T. J. (2012). An in vitro model of ischemic stroke. Astrocytes: Methods and Protocols, 451-466.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#In_Vitro_Model_of_Stroke</IRI>
        <Literal>In Vitro Model of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#In_Vivo_Model_of_Stroke</IRI>
        <Literal>In Vivo Models of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#In_Vivo_Model_of_Stroke</IRI>
        <Literal>In Vivo Model of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#InputDevices</IRI>
        <Literal>These devices are use to communicate your intentions and actions to the virtual world.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#InputDevices</IRI>
        <Literal>Input Devices</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Interactivity</IRI>
        <Literal>It provides users with comfortable, natural experience in engaging with the virtual world.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Interactivity</IRI>
        <Literal>Interactivity</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Intracerebral_Hemorrhage</IRI>
        <Literal>Intracerebral hemorrhage (ICH) occurs as a result of bleeding from an arterial source directly into the brain parenchyma, predominantly in the deep portions of the cerebral hemispheres (typical ICH).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Intracerebral_Hemorrhage</IRI>
        <Literal>Brainin, M., &amp; Heiss, W. D. (Eds.). (2014). Textbook of stroke medicine. Cambridge University Press.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Intracerebral_Hemorrhage</IRI>
        <Literal>Cerebral Brain Hemorrhages</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Intracerebral_Hemorrhage</IRI>
        <Literal>Cerebral Parenchymal Hemorrhage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Intracerebral_Hemorrhage</IRI>
        <Literal>Cerebrum Hemorrhage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Intracerebral_Hemorrhage</IRI>
        <Literal>Intracerebral Hemorrhages</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Intracerebral_Hemorrhage</IRI>
        <Literal>Intracerebral Hemorrhage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Intracranial_Hemorrhage</IRI>
        <Literal>A hemorrhagic stroke is one in which a blood vessel bursts and the blood creates pressure on the brain.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Intracranial_Hemorrhage</IRI>
        <Literal>Edlow, J. A. (2008). Stroke: Greenwood Press.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Intracranial_Hemorrhage</IRI>
        <Literal>Brain Haemorrhage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Intracranial_Hemorrhage</IRI>
        <Literal>Cerebral Haemorrhage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Intracranial_Hemorrhage</IRI>
        <Literal>Hemorrhagic Strokes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Intracranial_Hemorrhage</IRI>
        <Literal>Intracranial Haemorrhages</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Intracranial_Hemorrhage</IRI>
        <Literal>Intracranial Hemorrhage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Ischemic_Stroke</IRI>
        <Literal>An ischemic stroke is one in which a solid blood clot blocks the flow of blood in an artery to the brain. This clot obstructs the flow of blood so that any brain tissue that normally is fed by this artery is deprived of the nutrients (oxygen and glucose) that are normally supplied.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Ischemic_Stroke</IRI>
        <Literal>Edlow, J. A. (2008). Stroke: Greenwood Press.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ischemic_Stroke</IRI>
        <Literal>AIS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ischemic_Stroke</IRI>
        <Literal>Acute Cerebral Ischemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ischemic_Stroke</IRI>
        <Literal>Acute Ischemic Infarct</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ischemic_Stroke</IRI>
        <Literal>Acute Ischemic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ischemic_Stroke</IRI>
        <Literal>Embolic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ischemic_Stroke</IRI>
        <Literal>Focal Ischemic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ischemic_Stroke</IRI>
        <Literal>Occlusive Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Ischemic_Stroke</IRI>
        <Literal>Thrombotic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Ischemic_Stroke</IRI>
        <Literal>Ischemic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Joystick</IRI>
        <Literal>Joystick</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Laptop</IRI>
        <Literal>A virtual reality ready laptop is simply any machine that has the power to run the graphics and processing requirements of a virtual reality headset while tethered.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Laptop</IRI>
        <Literal>Laptop</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Leukoaraiosis</IRI>
        <Literal>Leuko-araiosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Leukoaraiosis</IRI>
        <Literal>Periventricular white matter disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Leukoaraiosis</IRI>
        <Literal>http://www.uptodate.com/contents/ischemic-stroke-prognosis-in-adults</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Leukoaraiosis</IRI>
        <Literal>Leukoaraiosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Life_Style_Modification</IRI>
        <Literal>Life Style Modification</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Life_Style_modification</IRI>
        <Literal>Life Style Modification</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Liu_Index</IRI>
        <Literal>The Liu Index was constructed specifically for use in stroke outcome research.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Liu_Index</IRI>
        <Literal>Karatepe, A. G., Gunaydin, R., Kaya, T., &amp; Turkmen, G. (2008). Comorbidity in patients after stroke: impact on functional outcome. Journal of rehabilitation medicine, 40(10), 831-835.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Liu_Index</IRI>
        <Literal>Liu Index</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Low_Birth_Weight</IRI>
        <Literal>History Low Birth Weight</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Low_Birth_Weight</IRI>
        <Literal>Low Birth Weight</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Low_Hemoglobin_Level</IRI>
        <Literal>http://www.uptodate.com/contents/ischemic-stroke-prognosis-in-adults</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Low_Hemoglobin_Level</IRI>
        <Literal>Low Hemoglobin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Magnetometer</IRI>
        <Literal>A magnetometer is a device used to measure the magnetic field, particularly with respect to its magnetic strength and orientation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Magnetometer</IRI>
        <Literal>Magnetometer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Mathematical_Model_of_Stroke</IRI>
        <Literal>mathematical modeling provides unique opportunities to coherently integrate complementary data from different scientific disciplines, such as molecular cell biology, cell and tissue microscopy, functional testing and clinical diagnostics, thereby enabling a better and more comprehensive understanding of physiological and patho-physiological processes.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Mathematical_Model_of_Stroke</IRI>
        <Literal>http://www.item.fraunhofer.de/en/focuses_of_research/tumortherapy/mathematical-modeling-of-disease-processes.html</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Mathematical_Model_of_Stroke</IRI>
        <Literal>Mathematical Model of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Measurement_of_Body_Mass_Index</IRI>
        <Literal>BMI Measurement</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Measurement_of_Body_Mass_Index</IRI>
        <Literal>Measurement of BMI</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Measurement_of_Body_Mass_Index</IRI>
        <Literal>Measurement of Body Mass Index</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Measures_of_Comorbidity</IRI>
        <Literal>In epidemiology, a rating scale for comorbidity.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Measures_of_Comorbidity</IRI>
        <Literal>http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C19253</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Measures_of_Comorbidity</IRI>
        <Literal>Comorbidity Index</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Measures_of_Comorbidity</IRI>
        <Literal>Measures of Comorbidity</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Mental_Immersion</IRI>
        <Literal>A deep engagement state where our mind suspends the disbelief that we are in virtual environment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Mental_Immersion</IRI>
        <Literal>Mental Immersion</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Metabolic_disease</IRI>
        <Literal>Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Metabolic_disease</IRI>
        <Literal>Metabolic Disorder</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Metabolic_disease</IRI>
        <Literal>Metabolic Disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Model_of_Stroke</IRI>
        <Literal>The eventual goal of modeling in stroke is to assist in prevention and therapy. These include the identification of approaches to reduce risk, development of treatments that can protect the brain at the time of stroke, and development of treatments to restore function and improve long-term outcome.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Model_of_Stroke</IRI>
        <Literal>Seidenstein, A. H., Barone, F. C., &amp; Lytton, W. W. (2015). Computer modeling of ischemic stroke. Scholarpedia Journal, 10(3), 32015. http://doi.org/10.4249/scholarpedia.32015</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Model_of_Stroke</IRI>
        <Literal>Stroke Model</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Model_of_Stroke</IRI>
        <Literal>Model of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Model_of_Stroke_Care</IRI>
        <Literal>Models of stroke care are necessary to estimate the long-term cost impact and consequences of interventions as well as the impact on the economic results of varying assumptions about risks of events, effectiveness of therapy, the cost of the intervention itself, and patient care.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Model_of_Stroke_Care</IRI>
        <Literal>Chambers, M. G., Koch, P., &amp; Hutton, J. (2002). Development of a DecisionAnalytic Model of Stroke Care in the United States and Europe. Value in Health, 5(2), 82-97.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Model_of_Stroke_Care</IRI>
        <Literal>Model of Stroke Care</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Modifiable_Risk_Factors</IRI>
        <Literal>Modifiable Risk Factor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Modifiable_Risk_Factors</IRI>
        <Literal>Modifiable Risk Factors</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Molecular_Biomarkers_of_Stroke</IRI>
        <Literal>Blood Biomarker of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Molecular_Biomarkers_of_Stroke</IRI>
        <Literal>Cellular Biomarkers of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Molecular_Biomarkers_of_Stroke</IRI>
        <Literal>Cerebrospinal Fluid Biomarkers of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Molecular_Biomarkers_of_Stroke</IRI>
        <Literal>Serum Biomarkers of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Molecular_Biomarkers_of_Stroke</IRI>
        <Literal>Molecular Biomarkers of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Motion_Tracker</IRI>
        <Literal>Motion Tracker</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Myocardial_Infarction</IRI>
        <Literal>Heart Attack</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Myocardial_Infarction</IRI>
        <Literal>Infarction of Heart</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Myocardial_Infarction</IRI>
        <Literal>MI</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Myocardial_Infarction</IRI>
        <Literal>Myocardial Infarction</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Neoplasm</IRI>
        <Literal>http://www.uptodate.com/contents/ischemic-stroke-prognosis-in-adults</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Neoplasm</IRI>
        <Literal>Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Neoplasm</IRI>
        <Literal>Tumor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Neoplasm</IRI>
        <Literal>Neoplasm</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Network_Model_of_Stroke</IRI>
        <Literal>Network Models of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Network_Model_of_Stroke</IRI>
        <Literal>Network Model of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Neurogenic_Bladder</IRI>
        <Literal>Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Neurogenic_Bladder</IRI>
        <Literal>Karatepe, A. G., Gunaydin, R., Kaya, T., &amp; Turkmen, G. (2008). Comorbidity in patients after stroke: impact on functional outcome. Journal of rehabilitation medicine, 40(10), 831-835.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Neurogenic_Bladder</IRI>
        <Literal>http://purl.bioontology.org/ontology/MESH/D001750</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Neurogenic_Bladder</IRI>
        <Literal>Neurogenic Bladder</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Neuroimaging_Biomarkers_of_Stroke</IRI>
        <Literal>Neuroimaging is widely used to aid in the diagnosis of stroke, to assist in determining a likely etiology for the event, to estimate severity, and to predict functional outcome and risk of recurrence.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Neuroimaging_Biomarkers_of_Stroke</IRI>
        <Literal>Maas, M. B., &amp; Furie, K. L. (2009). Molecular biomarkers in stroke diagnosis and prognosis. Biomarkers in medicine, 3(4), 363-383.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Neuroimaging_Biomarkers_of_Stroke</IRI>
        <Literal>SIM</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Neuroimaging_Biomarkers_of_Stroke</IRI>
        <Literal>Stroke Imaging Marker</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Neuroimaging_Biomarkers_of_Stroke</IRI>
        <Literal>Stroke Imaging Markers</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Neuroimaging_Biomarkers_of_Stroke</IRI>
        <Literal>Neuroimaging Biomarkers of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Non_Immersive</IRI>
        <Literal>It is virtual reality implemented at the lowest level. Here, tne user&apos;s senses are not fully stimulated and thereby allows peripheral awareness outside the virtual world.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Non_Immersive</IRI>
        <Literal>Non Immersive</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Nonmodifiable_Risk_Factors</IRI>
        <Literal>Nonmodifiable Risk Factors</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Nonmodifiable_Risk_Factors</IRI>
        <Literal>Nonmodifiable Risk Factors</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Nutritional_Counseling</IRI>
        <Literal>Individualized Nutritional Counseling</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Nutritional_Counseling</IRI>
        <Literal>Nutritional Counseling</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#OMICS_Biomarkers_of_Stroke</IRI>
        <Literal>OMICS Biomarkers of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#OMICS_Biomarkers_of_Stroke</IRI>
        <Literal>OMICS Biomarker of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#OWLClass_34bc4341_294f_46be_a29d_ed6e1061ea3a</IRI>
        <Literal>Education Intervention</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#OWLClass_34bc4341_294f_46be_a29d_ed6e1061ea3a</IRI>
        <Literal>Educational Intervention</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#OWLClass_34bc4341_294f_46be_a29d_ed6e1061ea3a</IRI>
        <Literal xml:lang="en">Education</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#OWLClass_3a1ae59a_d940_49d6_b133_1b7ad71c26f9</IRI>
        <Literal xml:lang="en">Rehabilitation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#OWLClass_c2830a4c_f4d1_403d_8bbf_dfa0174f1d9f</IRI>
        <Literal>Stroke in children differ from those in adults in three important ways: predisposing factors, clinical evolution, and anatomic site of pathology.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#OWLClass_c2830a4c_f4d1_403d_8bbf_dfa0174f1d9f</IRI>
        <Literal>Merritt, H. H. (2010). Merritt&apos;s neurology. L. P. Rowland, &amp; T. A. Pedley (Eds.). Lippincott Williams &amp; Wilkins.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#OWLClass_c2830a4c_f4d1_403d_8bbf_dfa0174f1d9f</IRI>
        <Literal>Hemorrhagic Stroke in Children</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#OWLClass_c2830a4c_f4d1_403d_8bbf_dfa0174f1d9f</IRI>
        <Literal>Pediatric Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#OWLClass_c2830a4c_f4d1_403d_8bbf_dfa0174f1d9f</IRI>
        <Literal xml:lang="en">Pediatric Hemorrhagic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#OWLClass_e8555bce_f177_4aea_86c3_f65555f414b7</IRI>
        <Literal xml:lang="en">Life Style Modification</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#OWLObjectProperty_0378bc7f_def8_4536_ab6a_d88c34fe04df</IRI>
        <Literal xml:lang="en">is_a</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#OWLObjectProperty_2e92b949_4d60_48b4_b2f3_9b411f818aaa</IRI>
        <Literal xml:lang="en">describes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#OWLObjectProperty_31c75e97_ce08_416d_9f73_8e8d925625cb</IRI>
        <Literal xml:lang="en">causes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#OWLObjectProperty_5615cbc1_65c9_4e29_98d3_377529b10061</IRI>
        <Literal xml:lang="en">contained_in</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#OWLObjectProperty_84d46f2b_d0ec_4792_bbcf_0f8339f7b468</IRI>
        <Literal xml:lang="en">preceded_by</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#OWLObjectProperty_c47210a3_bde8_4bcc_bf78_95c620906491</IRI>
        <Literal xml:lang="en">result_in</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#OWLObjectProperty_db528468_dcd4_4048_8fd7_eed7a668add5</IRI>
        <Literal xml:lang="en">participated_in</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#OWLObjectProperty_ee1a2701_b93b_4a04_b72d_3bfd6ae3a7eb</IRI>
        <Literal xml:lang="en">part_of</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Obesity</IRI>
        <Literal>A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Obesity</IRI>
        <Literal>Adiposis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Obesity</IRI>
        <Literal>Adiposity</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Obesity</IRI>
        <Literal>Obesity</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Orpington_Prognostic_Scale</IRI>
        <Literal>The Orpington Prognostic Scale and the NIH Stroke Scale were used to measure stroke severity at baseline. The Orpington Prognostic Scale includes measures of motor deficit in arm, proprioception, balance, and cognition.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Orpington_Prognostic_Scale</IRI>
        <Literal>Lai, S. M., Duncan, P. W., &amp; Keighley, J. (1998). Prediction of functional outcome after stroke comparison of the Orpington Prognostic Scale and the NIH Stroke Scale. Stroke, 29(9), 1838-1842.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Orpington_Prognostic_Scale</IRI>
        <Literal>OPS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Orpington_Prognostic_Scale</IRI>
        <Literal>Orpington Prognostic Scale</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Osteoarthritis</IRI>
        <Literal>A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Osteoarthritis</IRI>
        <Literal>Karatepe, A. G., Gunaydin, R., Kaya, T., &amp; Turkmen, G. (2008). Comorbidity in patients after stroke: impact on functional outcome. Journal of rehabilitation medicine, 40(10), 831-835.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Osteoarthritis</IRI>
        <Literal>http://purl.bioontology.org/ontology/MESH/D010003</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Osteoarthritis</IRI>
        <Literal>Osteoarthritis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Outcome</IRI>
        <Literal>Outcome of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Outcome</IRI>
        <Literal>Outcomes of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Outcome</IRI>
        <Literal>Stroke Outcome</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Outcome</IRI>
        <Literal>Stroke Outcomes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Outcome</IRI>
        <Literal>Outcome</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Oxygen_Desaturation</IRI>
        <Literal>https://www.uptodate.com/contents/stroke-related-pulmonary-complications-and-abnormal-respiratory-patterns?source=see_link</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Oxygen_Desaturation</IRI>
        <Literal>Oxygen Desaturation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#PC</IRI>
        <Literal>A virtual reality personal computer is simply any machine that has the power to run the graphics and processing requirements of a virtual reality headset while tethered.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#PC</IRI>
        <Literal>PC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pathophysiology_Hemorrhagic_Stroke</IRI>
        <Literal>Pathophysiology of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Pathophysiology_Hemorrhagic_Stroke</IRI>
        <Literal>Pathophysiology of Hemorrhagic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Pathophysiology_of_Ischemic_Stroke</IRI>
        <Literal>The pathophysiology of any disease is how the normal physiology is altered by a disease, or pathologic, process.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Pathophysiology_of_Ischemic_Stroke</IRI>
        <Literal>Edlow, J. A. (2008). Stroke: Greenwood Press.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Pathophysiology_of_Ischemic_Stroke</IRI>
        <Literal>Pathophysiology of Ischemic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Pediatric_Ischemic_Stroke</IRI>
        <Literal>Merritt, H. H. (2010). Merritt&apos;s neurology. L. P. Rowland, &amp; T. A. Pedley (Eds.). Lippincott Williams &amp; Wilkins.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pediatric_Ischemic_Stroke</IRI>
        <Literal>Ischemic Stroke in Children</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pediatric_Ischemic_Stroke</IRI>
        <Literal>Pediatric Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Pediatric_Ischemic_Stroke</IRI>
        <Literal>Pediatric Ischemic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Physical_Biomarkers_of_Stroke</IRI>
        <Literal>A physical marker associated with stroke may be as simple as the discovery of hypertension.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Physical_Biomarkers_of_Stroke</IRI>
        <Literal>Maas, M. B., &amp; Furie, K. L. (2009). Molecular biomarkers in stroke diagnosis and prognosis. Biomarkers in medicine, 3(4), 363-383.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Physical_Biomarkers_of_Stroke</IRI>
        <Literal>Physical Markers of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Physical_Biomarkers_of_Stroke</IRI>
        <Literal>Physical Biomarkers of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Physical_Immersion</IRI>
        <Literal>Physical engagement demostrated in the virtual world that makes our mind to suspend the disblief that we are in a virtual environment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Physical_Immersion</IRI>
        <Literal>Physical Immersion</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Playstation</IRI>
        <Literal>A playstation is a virtual reality headset that you can use to watch movies, play games and even go on tours. It&apos;s like having your own private cinema or theatre in the comfort of your home.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Playstation</IRI>
        <Literal>Playstation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Pneumonia</IRI>
        <Literal>https://www.uptodate.com/contents/medical-complications-of-stroke?source=see_link#H14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Pneumonia</IRI>
        <Literal>Pneumonia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Poor_Nutritional_Status</IRI>
        <Literal>http://www.uptodate.com/contents/ischemic-stroke-prognosis-in-adults</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Poor_Nutritional_Status</IRI>
        <Literal>Poor Nutritional Status</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Porcine_Ischemic_Stroke_Model</IRI>
        <Literal>Zhang R, Bertelsen LB, Fl C, Wang Y, Stdkilde-Jrgensen H. Establishment and
characterization of porcine focal cerebral ischemic model induced by
endothelin-1. Neurosci Lett. 2016 Dec 2;635:1-7.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Porcine_Ischemic_Stroke_Model</IRI>
        <Literal>endothelin-1 induced porcine cerebral ischemic model</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Porcine_Ischemic_Stroke_Model</IRI>
        <Literal>porcine endothelin-1 induced models</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Porcine_Ischemic_Stroke_Model</IRI>
        <Literal>Porcine Ischemic Stroke Model</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Post_Stroke_Comorbidity</IRI>
        <Literal>Post Stroke Comorbidity</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Poststroke_Hyperglycemia</IRI>
        <Literal>Selvarajah D, Tesfaye S. Central nervous system involvement in diabetes mellitus. Curr Diab Rep. 2006 Dec;6(6):431-8. Review. PubMed PMID: 17118225</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Poststroke_Hyperglycemia</IRI>
        <Literal>Poststroke Hyperglycemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Posttranscriptional_Gene_Silencing</IRI>
        <Literal>Rink, C., &amp; Khanna, S. (2011). MicroRNA in ischemic stroke etiology and pathology. Physiological genomics, 43(10), 521-528.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Posttranscriptional_Gene_Silencing</IRI>
        <Literal>Post-transcriptional Gene Silencing</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Posttranscriptional_Gene_Silencing</IRI>
        <Literal>Posttranscriptional Gene Silencing</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Prestroke_Comorbidity</IRI>
        <Literal>Prestroke Comorbidity</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Primary_Hypercholesteremia</IRI>
        <Literal>Primary Hypercholesterolaemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Primary_Hypercholesteremia</IRI>
        <Literal>Primary Hypercholesterolemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Primary_Hypertriglyceridemia</IRI>
        <Literal>Primary Hypertriglyceridemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Primary_Prevention_of_Stroke</IRI>
        <Literal>Merritt, H. H. (2010). Merritt&apos;s neurology. L. P. Rowland, &amp; T. A. Pedley (Eds.). Lippincott Williams &amp; Wilkins.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Primary_Prevention_of_Stroke</IRI>
        <Literal>Prevent First Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Primary_Prevention_of_Stroke</IRI>
        <Literal>Primary Stroke Prevention</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Primary_Prevention_of_Stroke</IRI>
        <Literal>Primary Prevention of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Prior_Stroke</IRI>
        <Literal>Prior stroke is a strong predisposing risk factor for new stroke and is the most common disease with ICH.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Prior_Stroke</IRI>
        <Literal>Jerntorp, P., &amp; Berglund, G. (1992). Stroke registry in Malm, Sweden. Stroke, 23(3), 357-361.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Prior_Stroke</IRI>
        <Literal>Old CVA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Prior_Stroke</IRI>
        <Literal>Old Cerebrovascular Accident</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Prior_Stroke</IRI>
        <Literal>Old Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Prior_Stroke</IRI>
        <Literal>Prior Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Process_Acceleration_Card</IRI>
        <Literal>Process Acceleration Cards</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Prognosis</IRI>
        <Literal>A prediction of the probable outcome of a disease based on a individual&apos;s condition and the usual course of the disease as seen in similar situations.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Prognosis</IRI>
        <Literal>http://purl.bioontology.org/ontology/MESH/D011379</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Prognosis</IRI>
        <Literal>Prognoses</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Prognosis</IRI>
        <Literal>Prognosis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Proximity_Sensor</IRI>
        <Literal>A proximity sensor is a component which is designed to detect the absence or presence of an object without the need for physical contact</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Proximity_Sensor</IRI>
        <Literal>Proximity Sensor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Pulmonary_Embolism</IRI>
        <Literal>Pulmonary embolism is an obstruction of a blood vessel in the lungs, usually due to a blood clot, which blocks a coronary artery.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Pulmonary_Embolism</IRI>
        <Literal>pulmonary embolism. (n.d.) Gale Encyclopedia of Medicine. (2008). Retrieved December 20 2015 from http://medical-dictionary.thefreedictionary.com/pulmonary+embolism</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Pulmonary_Embolism</IRI>
        <Literal>PE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Pulmonary_Embolism</IRI>
        <Literal>Pulmonary Embolism</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Race</IRI>
        <Literal>Ethnic</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Race</IRI>
        <Literal>Ethnicity</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Race</IRI>
        <Literal>Race Relations</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Race</IRI>
        <Literal>Race</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Renal_Dysfunction</IRI>
        <Literal>http://www.uptodate.com/contents/ischemic-stroke-prognosis-in-adults</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Renal_Dysfunction</IRI>
        <Literal>Dialysis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Renal_Dysfunction</IRI>
        <Literal>Renal Dysfunction</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Risk_Factor</IRI>
        <Literal>An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Risk_Factor</IRI>
        <Literal>http://purl.bioontology.org/ontology/MESH/D012307</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Risk_Factor</IRI>
        <Literal>Risk Factors of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Risk_Factor</IRI>
        <Literal>Risk of Hemorrhagic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Risk_Factor</IRI>
        <Literal>Risk of Ischemic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Risk_Factor</IRI>
        <Literal>Stroke Risk Factor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Risk_Factor</IRI>
        <Literal>Risk Factor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Risk_Factor_Reduction</IRI>
        <Literal>Risk-reduction measures in primary stroke prevention may include the use of antihypertensive medications; warfarin; platelet antiaggregants; 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins); smoking cessation; dietary intervention; weight loss; and exercise. Modifiable risk factors include the following: Hypertension, Cigarette smoking, Diabetes, Dyslipidemiam, Atrial fibrillation, Sickle cell disease, Postmenopausal HRT, Depression, Diet and activity, Weight and body fat.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Risk_Factor_Reduction</IRI>
        <Literal>Pearson, T. A., Blair, S. N., Daniels, S. R., Eckel, R. H., Fair, J. M., Fortmann, S. P., ... &amp; Hong, Y. (2002). AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation, 106(3), 388-391.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Risk_Factor_Reduction</IRI>
        <Literal>Risk Factor Reduction</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Scales</IRI>
        <Literal>Stroke scales are useful for clinical and research purposes as aids to improve diagnostic accuracy, determine the suitability of specific treatments, monitor change in neurologic impairments, and predict and measure outcomes.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Scales</IRI>
        <Literal>Asplund K. Clinimetrics in stroke research. Stroke 1987; 18:528.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Scales</IRI>
        <Literal>Classification Systems</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Scales</IRI>
        <Literal>Grading</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Scales</IRI>
        <Literal>Scoring Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Scales</IRI>
        <Literal>Scoring Systems</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Scales</IRI>
        <Literal>Scales</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Screening_for_Diabetic_Mellitus</IRI>
        <Literal>After a TIA or ischemic stroke, all patients should probably be screened for DM with testing of fasting plasma glucose, HbA1c, or an oral glucose tolerance test.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Screening_for_Diabetic_Mellitus</IRI>
        <Literal>Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., ... &amp; Johnston, S. C. C. (2014). Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 45(7), 2160-2236.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Screening_for_Diabetic_Mellitus</IRI>
        <Literal>Screenung for DM</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Screening_for_Diabetic_Mellitus</IRI>
        <Literal>Screening for Diabetic Mellitus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Screening_for_Sleep_Apnea</IRI>
        <Literal>Screening for Sleep Apnea</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Secondary_Hypercholesteremia</IRI>
        <Literal>Secondary Hypercholesterolaemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Secondary_Hypercholesteremia</IRI>
        <Literal>Secondary Hypercholesterolemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Secondary_Hyperlipidemia</IRI>
        <Literal>Secondary hyperlipidaemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Secondary_Hyperlipidemia</IRI>
        <Literal>Secondary Hyperlipidemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Secondary_Hypertriglyceridemia</IRI>
        <Literal>Secondary Hypertriglyceridaemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Secondary_Hypertriglyceridemia</IRI>
        <Literal>Secondary Hypertriglyceridemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Secondary_Prevention_of_Stroke</IRI>
        <Literal>Merritt, H. H. (2010). Merritt&apos;s neurology. L. P. Rowland, &amp; T. A. Pedley (Eds.). Lippincott Williams &amp; Wilkins.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Secondary_Prevention_of_Stroke</IRI>
        <Literal>Avert Stroke Recurrences</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Secondary_Prevention_of_Stroke</IRI>
        <Literal>Secondary Stroke Prevention</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Secondary_Prevention_of_Stroke</IRI>
        <Literal>Secondary Prevention of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Self_Monitoring_of_Blood_Pressure</IRI>
        <Literal>Home Self-Monitoring of Blood Pressure</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Self_Monitoring_of_Blood_Pressure</IRI>
        <Literal>Self Monitoring of BP</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Self_Monitoring_of_Blood_Pressure</IRI>
        <Literal>Self Monitoring of Blood Pressure</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Semantic_Model_of_Stroke</IRI>
        <Literal>a semantic model for cerebrovascular accidents allows the integration of clinical and genetic data and the automated interconnection with outside resources (like SNOMED CT) in order to evaluate their individual and combined weight in the patient recovery score.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Semantic_Model_of_Stroke</IRI>
        <Literal>Silvaa, L., Coutoa, F., Mansob, H., &amp; Vicenteb, A. Development of a semantic model for Cerebrovascular Accident (CVA) Patients. 2014</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Semantic_Model_of_Stroke</IRI>
        <Literal>Semantic Model of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Semi_Immersive</IRI>
        <Literal>Semi immersive environment provides for a better immersion experience where the user is only partly immersed in the virtual world.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Semi_Immersive</IRI>
        <Literal>Semi Immersive</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Sensing_Glove</IRI>
        <Literal>The aim of the sensing gloves is to allow user handling of virtual objects</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Sensing_Glove</IRI>
        <Literal>Sensing Glove</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Sensory_Displays</IRI>
        <Literal>These are used to supply your senses with information from the computer-generated reality in much the same way as you experience the real world.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Sensory_Displays</IRI>
        <Literal>Sensory Displays</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Sensory_Feedback</IRI>
        <Literal>Sensory feedback is required for properly stimulating our sense by the virtual reality into play which includes visual, touch, aural and more.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Sensory_Feedback</IRI>
        <Literal>Sensory Feedback</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Shoulder_Pain</IRI>
        <Literal>Unilateral or bilateral pain of the shoulder. It is often caused by physical activities such as work or sports participation, but may also be pathologic in origin.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Shoulder_Pain</IRI>
        <Literal>Karatepe, A. G., Gunaydin, R., Kaya, T., &amp; Turkmen, G. (2008). Comorbidity in patients after stroke: impact on functional outcome. Journal of rehabilitation medicine, 40(10), 831-835.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Shoulder_Pain</IRI>
        <Literal>http://purl.bioontology.org/ontology/MESH/D020069</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Shoulder_Pain</IRI>
        <Literal>Pain of Shoulder</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Shoulder_Pain</IRI>
        <Literal>Shoulder Pain</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Shwartz_Index</IRI>
        <Literal>The Shwartz Index consists of 21 weighted conditions and evaluates the negative influence of comorbid conditions on the treatment of the primary condition, including stroke, lung disease, heart disease, prostate disease, low back disorders, and hip fracture.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Shwartz_Index</IRI>
        <Literal>Karatepe, A. G., Gunaydin, R., Kaya, T., &amp; Turkmen, G. (2008). Comorbidity in patients after stroke: impact on functional outcome. Journal of rehabilitation medicine, 40(10), 831-835.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Shwartz_Index</IRI>
        <Literal>Shwartz Index</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Smartphone</IRI>
        <Literal>Smartphone virtual reality headsets make use of smartphones to provide a virtual reality experience. Users slide their smartphone into headset for a wearable HDM; the screen will be right in front of the user&apos;s eyes, with a set of lenses that create a sense of depth.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Smartphone</IRI>
        <Literal>Smartphone</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Smoking</IRI>
        <Literal>Cigarette Smoking</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Smoking</IRI>
        <Literal>Cigarette Use</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Smoking</IRI>
        <Literal>Exposure to Cigarette Smoke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Smoking</IRI>
        <Literal>Smooking</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Snoring</IRI>
        <Literal>Habitual Snoring</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Snoring</IRI>
        <Literal>Snorings</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Snoring</IRI>
        <Literal>Snoring</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Stroke</IRI>
        <Literal>Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Stroke_Center</IRI>
        <Literal>Stroke Center</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Stroke_Mimics</IRI>
        <Literal>Stroke Mimics</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Stroke_Prevention</IRI>
        <Literal>Used with disease headings for increasing human or animal resistance against disease (e.g., immunization), for control of transmission agents, for prevention and control of environmental hazards, or for prevention and control of social factors leading to disease. It includes preventive measures in individual cases.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Stroke_Prevention</IRI>
        <Literal>http://purl.bioontology.org/ontology/MESH/Q000517</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stroke_Prevention</IRI>
        <Literal>CVA Prevention</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stroke_Prevention</IRI>
        <Literal>Cerebrovascular Accident Prevention</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stroke_Prevention</IRI>
        <Literal>Prevention of CVA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stroke_Prevention</IRI>
        <Literal>Prevention of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Stroke_Prevention</IRI>
        <Literal>Stroke Prevention</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Stroke_Type</IRI>
        <Literal>Intraparenchymal intracranial hemorrhage from a variety of causes - the spontaneous or hypertensive hemorrhages, vascular malformations, or aneurysmal origin -are frequently encountered clinically and figure prominently in the initial stroke differential diagnosis. These different processes may be considered stroke subtypes for classification purposes.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Stroke_Type</IRI>
        <Literal>Emerg Med Clin North Am. 2002 Aug;20(3):583-95. Stroke mimics and chameleons.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Stroke_Type</IRI>
        <Literal>Type of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Stroke_Type</IRI>
        <Literal>Stroke Type</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Stroke_team</IRI>
        <Literal>This is another concept borrowed from trauma care. In larger hospitals, when a severely traumatized patient arrives in the ED, for example after a severe car crash, a team of physicians, nurses, and other healthcare providers collect and work collaboratively to rapidly assess and treat the patient. This same concept is now being applied to stroke victims.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Stroke_team</IRI>
        <Literal>Edlow, J. A. (2008). Stroke: Greenwood Press.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Stroke_team</IRI>
        <Literal>Stroke Team</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Subarachnoid_Hemorrhage</IRI>
        <Literal>A subarachnoid hemorrhage (SAH) is bleeding into the subarachnoid space that exists between the arachnoid and pia membranes that surround the brain.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Subarachnoid_Hemorrhage</IRI>
        <Literal>Roth, E. J. (2011). Subarachnoid Hemorrhage. In Encyclopedia of Clinical Neuropsychology (pp. 2423-2423). Springer New York.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Subarachnoid_Hemorrhage</IRI>
        <Literal>Aneurysmal Subarachnoid Hemorrhage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Subarachnoid_Hemorrhage</IRI>
        <Literal>SAH</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Subarachnoid_Hemorrhage</IRI>
        <Literal>Subarachnoid Haemorrhage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Subarachnoid_Hemorrhage</IRI>
        <Literal>Subarachnoid Hemorrhages</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Subarachnoid_Hemorrhage</IRI>
        <Literal>Subarachnoid Hemorrhage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Symptom_of_Hemorrhagic_Stroke</IRI>
        <Literal>The symptoms of a hemorrhagic stroke caused by an embolism usually appear suddenly and are most intense right after the stroke occurs.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Symptom_of_Hemorrhagic_Stroke</IRI>
        <Literal>Department of Health, Western Australia. Model of Stroke Care 2012.  Perth: Health Networks Branch, Department of Health, Western Australia; 2012.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Symptom_of_Hemorrhagic_Stroke</IRI>
        <Literal>Symptom of Hemorrhagic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Symptom_of_Ischemic_Stroke</IRI>
        <Literal>The symptoms of a ischemic stroke caused by an embolism usually appear suddenly and are most intense right after the stroke occurs.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Symptom_of_Ischemic_Stroke</IRI>
        <Literal>Department of Health, Western Australia. Model of Stroke Care 2012.  Perth: Health Networks Branch, Department of Health, Western Australia; 2012.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Symptom_of_Ischemic_Stroke</IRI>
        <Literal>Symptom</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Symptom_of_Ischemic_Stroke</IRI>
        <Literal>Syndromes of Ischemic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Symptom_of_Ischemic_Stroke</IRI>
        <Literal>Symptom of Ischemic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Telemedicine</IRI>
        <Literal>Delivery of health services via remote telecommunications. This includes interactive consultative and diagnostic services. Health services supported by remote or mobile devices.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Telemedicine</IRI>
        <Literal>Telemedicine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Telestroke</IRI>
        <Literal>Telestroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Temperature_Control</IRI>
        <Literal>Temperature Control</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Tobacco_Use</IRI>
        <Literal>Tobacco</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Tobacco_Use</IRI>
        <Literal>Tobacco Use</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Tracking_Pad</IRI>
        <Literal>Tracking Pad</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Tracking_System</IRI>
        <Literal>The tracking system measures position and orientation of the virtual world.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Tracking_System</IRI>
        <Literal>Tracking System</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Training</IRI>
        <Literal>Virtual reality training is an immersive learning experience that recreates real life settings and simulates work challenges. It gives employees the chances to gain on the job training in a risk-free environment where they can learn by doing. This include Military Training, Workfoce Training, Procedural Training, Medical Training etc.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Training</IRI>
        <Literal>Training</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Treadmills</IRI>
        <Literal>Treadmills</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Treatment</IRI>
        <Literal>Used with diseases for therapeutic interventions except drug therapy, diet therapy, radiotherapy, and surgery, for which specific subheadings exist. The concept is also used for articles and books dealing with multiple therapies. [MeSH] [LIRADS] Intervention with the intent to slow the growth, cause necrosis, or resect from the liver an HCC. Examples include surgical resection, ablation, chemoembolization, radiation, and systemic chemotherapy.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Treatment</IRI>
        <Literal>Department of Health, Western Australia. Model of Stroke Care 2012.  Perth: Health Networks Branch, Department of Health, Western Australia; 2012.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Treatment</IRI>
        <Literal>http://www.owl-ontologies.com/Ontology1447432460.owl#RID8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Treatment</IRI>
        <Literal>Therapeutics</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Treatment</IRI>
        <Literal>Therapies</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Treatment</IRI>
        <Literal>Therapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Treatment</IRI>
        <Literal>Treatments</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Treatment</IRI>
        <Literal>Treatment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Treatment_of_Hemorrhagic_Stroke</IRI>
        <Literal>Treatment for hemorrhagic stroke needs emergency medicines in order to prevent worsening of the situation or else it can be fatal. The aim of treatment for hemorrhagic stroke is to control bleeding and reduce the pressure caused by bleeding in the surrounding tissue.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Treatment_of_Hemorrhagic_Stroke</IRI>
        <Literal>http://www.epainassist.com/brain/hemorrhagic-stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Treatment_of_Hemorrhagic_Stroke</IRI>
        <Literal>Treatment of Hemorrhagic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Treatment_of_Ischemic_Stroke</IRI>
        <Literal>The goal of treatment of  ischemic stroke is to restore blood flow to the affected area of the brain as quickly as possible, which means within the first hours after the stroke begins.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Treatment_of_Ischemic_Stroke</IRI>
        <Literal>http://www.uptodate.com/contents/ischemic-stroke-treatment-beyond-the-basics</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Treatment_of_Ischemic_Stroke</IRI>
        <Literal>Treatment of Ischemic Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Treatment_of_Pain_and_Anxiety</IRI>
        <Literal>Treatment of Pain and Anxiety</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Type_2_Diabetes_Mellitus</IRI>
        <Literal>T2DM</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Type_2_Diabetes_Mellitus</IRI>
        <Literal>Type 2 DM</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Type_2_Diabetes_Mellitus</IRI>
        <Literal>Type 2 Diabetes Mellitus</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Urinary_Tract_Infection</IRI>
        <Literal>https://www.uptodate.com/contents/medical-complications-of-stroke?source=see_link#H14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Urinary_Tract_Infection</IRI>
        <Literal>UTI</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Urinary_Tract_Infection</IRI>
        <Literal>Urinary Tract Infection</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Virtual_Reality</IRI>
        <Literal>Virtual Reality</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Virtual_World</IRI>
        <Literal></Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Virtual_World</IRI>
        <Literal>It is a 3D environment that is mostly realized through rendering, displays or other such mediums. it allows user interactions that mimic real world experience. Here, visual perspectives are highly responsive to movement changes.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Virtual_World</IRI>
        <Literal>Virtual World</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#Visual_Impairment</IRI>
        <Literal>Limitation in visual functions. Visual impairments limiting one or more of the basic functions of the eye: visual acuity, dark adaptation, color vision, or peripheral vision. These may result from EYE DISEASES; OPTIC NERVE DISEASES; VISUAL PATHWAY diseases; OCCIPITAL LOBE diseases; OCULAR MOTILITY DISORDERS; and other conditions (From Newell, Ophthalmology: Principles and Concepts, 7th ed, p132).</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#Visual_Impairment</IRI>
        <Literal>Karatepe, A. G., Gunaydin, R., Kaya, T., &amp; Turkmen, G. (2008). Comorbidity in patients after stroke: impact on functional outcome. Journal of rehabilitation medicine, 40(10), 831-835.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#source"/>
        <IRI>#Visual_Impairment</IRI>
        <Literal>http://purl.bioontology.org/ontology/MESH/D014786</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#Visual_Impairment</IRI>
        <Literal>Visual Impairments</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Visual_Impairment</IRI>
        <Literal>Visual Impairment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <IRI>#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;</IRI>
        <Literal>A biomarker is any measurable physiological characteristic or substance that marks the risk for or manifestation of a stroke-related process.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#references"/>
        <IRI>#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;</IRI>
        <Literal>Maas, M. B., &amp; Furie, K. L. (2009). Molecular biomarkers in stroke diagnosis and prognosis. Biomarkers in medicine, 3(4), 363-383.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;</IRI>
        <Literal>Stroke Biomarker</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#synonyms"/>
        <IRI>#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;</IRI>
        <Literal>Stroke Biomarkers</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#&apos;Biomarkers_in_the_Diagnosis_of_Stroke&apos;</IRI>
        <Literal>Biomarkers in the Diagnosis of Stroke</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#&apos;Diagnostic_evaluation&apos;</IRI>
        <Literal>Diagnostic Evaluation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#2D_Graphics_Software</IRI>
        <Literal>2D Graphics Software</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty IRI="#defination"/>
        <AbbreviatedIRI>owl:Thing</AbbreviatedIRI>
        <Literal>Locomotion is one of the most signicant abilities of human beings. It allows people to move freely from one place to another and it is very important to maintain a good quality of our life. However, the process of moving from one place to another is a task critical to the independent function of the body, reflecting the ability to move efficiently and safely from one destination to another. More so, locomotion contributed a lot to the ability to engage in community activities, meaningful work, and leisure. The most important elements of locomotion include progression, adaptation, and stability.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>owl:Thing</AbbreviatedIRI>
        <Literal>Locomotion Rehabilitation</Literal>
    </AnnotationAssertion>
</Ontology>



<!-- Generated by the OWL API (version 4.5.9.2019-02-01T07:24:44Z) https://github.com/owlcs/owlapi -->

